###begin article-title 0
Critical role of phospholipase Cgamma2 in integrin and Fc receptor-mediated neutrophil functions and the effector phase of autoimmune arthritis
###end article-title 0
###begin p 1
###xml 4 5 1 2 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 473 476 458 461 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 521 522 503 504 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 744 747 718 721 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1042 1045 1012 1015 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1141 1142 1108 1109 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 1232 1236 <span type="species:ncbi:10090">mice</span>
beta2 integrins and Fcgamma receptors are critically involved in neutrophil activation at the site of inflammation. Both receptor types trigger a receptor-proximal tyrosine phosphorylation cascade through Src family kinases and Syk, but further downstream signaling events are poorly understood. We show that phospholipase C (PLC) gamma2 is phosphorylated downstream of Src family kinases and Syk during integrin or Fc receptor-mediated activation of neutrophils. PLCgamma2-/- neutrophils are completely defective in beta2 integrin or Fcgamma receptor-mediated functional responses such as respiratory burst, degranulation, or cell spreading in vitro and show reduced adhesion/spreading in inflamed capillary venules in vivo. However, PLCgamma2-/- neutrophils respond normally to various other agonists, including chemokines, bacterial formyl peptides, Toll-like receptor ligands, or proinflammatory cytokines, and migrate normally both in vitro and in vivo. To confirm the in vivo relevance of these observations, the effect of the PLCgamma2-/- mutation was tested in the K/BxN serum transfer arthritis model, which is known to require beta2 integrins, Fcgamma receptors, and neutrophils. PLCgamma2 deficiency completely protected mice from clinical signs and histological features of arthritis as well as from arthritis-induced loss of articular function. These results identify PLCgamma2 as a critical player of integrin and Fc receptor-mediated neutrophil functions and the neutrophil-mediated effector phase of autoimmune arthritis.
###end p 1
###begin p 2
###xml 180 181 180 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 182 183 182 183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 274 275 271 272 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Neutrophils play a critical role in innate immune defense, but their improper activation also contributes to tissue damage during autoimmune diseases such as rheumatoid arthritis (1-5). Neutrophils use several cell surface receptors to sense their environment including beta2 integrins, immunoglobulin Fc receptors, various G protein-coupled (e.g., formyl peptide or chemokine) receptors, Toll-like receptors, and receptors for various proinflammatory cytokines.
###end p 2
###begin p 3
###xml 379 380 375 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 382 383 378 379 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib7">7</xref>
###xml 581 582 570 571 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 699 700 688 689 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 702 703 691 692 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 787 789 772 774 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 821 823 806 808 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 944 946 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 960 962 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib12">12</xref>
###xml 978 980 963 965 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib13">13</xref>
###xml 1000 1002 985 987 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib14">14</xref>
###xml 1020 1022 1005 1007 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib15">15</xref>
###xml 1226 1228 1211 1213 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
Lymphocyte antigen receptors, Fcϵ receptors of mast cells, and Fcgamma receptors of macrophages use a common receptor-proximal signal transduction machinery consisting of the sequential activation of Src family kinases, immunoreceptor tyrosine-based activation motif (ITAM) containing transmembrane adapters, and the Syk or the ZAP-70 tyrosine kinase. Studies from other groups (6, 7) and our own unpublished observations indicate that neutrophil Fcgamma receptors also use a receptor-proximal Src family-ITAM-bearing adaptor-Syk signaling pathway. We have recently shown that beta2 integrins in neutrophils signal through a conceptually similar receptor-proximal pathway, using Src family kinases (8, 9), two ITAM-bearing transmembrane adapters (DAP12 and the Fc receptor gamma chain) (10), and the Syk tyrosine kinase (11). We and others have reported similar ITAM-based integrin signaling pathways in other cell types including macrophages (10), platelets (12), osteoclasts (13), dendritic cells (14), and microglia (15). Collectively, integrins and Fc receptors in various hematopoietic lineages signal through a conceptually similar ITAM-based receptor-proximal tyrosine phosphorylation cascade (for review see reference 16). However, the signal transduction mechanisms downstream of this common receptor-proximal pathway are poorly understood.
###end p 3
###begin p 4
###xml 218 220 218 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 727 729 704 706 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib17">17</xref>
###xml 731 733 708 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib18">18</xref>
###xml 872 874 845 847 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
Phosphoinositide-specific phospholipase C (PLC) enzymes catalyze the breakdown of the membrane lipid phosphatidylinositol-4,5-bisphosphate to inositol-3,4,5-trisphosphate and diacylglycerol, triggering a concomitant Ca2+ signal and protein kinase C activation. Of the best known PLC isoforms, the PLCbeta family is activated by G protein-coupled receptors, whereas the PLCgamma family is activated downstream of tyrosine phosphorylation pathways. There are two known PLCgamma isoforms: PLCgamma1 is ubiquitously expressed, whereas PLCgamma2 is preferentially expressed in the hematopoietic system. Genetic deficiency of PLCgamma1 leads to embryonic lethality, likely as a result of defective erythropoiesis and vasculogenesis (17, 18). In contrast, PLCgamma2-deficient mice are viable, their principal phenotype being a profound defect in B cell development and function (19).
###end p 4
###begin p 5
###xml 235 237 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
###xml 239 241 231 233 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 371 373 363 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
###xml 440 442 424 426 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 475 478 455 458 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 544 546 524 526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib20">20</xref>
Although PLCgamma2 is activated by various Fc receptors, its possible functional role downstream of those receptors is rather controversial. Genetic deficiency of PLCgamma2 attenuates Fcϵ receptor-mediated degranulation of mast cells (19, 20) but it does not affect extracellular signal-regulated kinase (ERK) activation or cytokine production under the same conditions (20). Although PLCgamma2 is required for Fcgamma receptor-triggered Ca2+ signal in macrophages, PLCgamma2-/- macrophages show normal phagocytosis of IgG-coated erythrocytes (20). The role of PLCgamma2 in Fc receptor-mediated functions in other cell types such as neutrophils is presently unknown.
###end p 5
###begin p 6
###xml 193 196 185 188 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 208 210 200 202 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 212 214 204 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 280 281 268 269 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 285 286 270 271 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
###xml 335 337 320 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib21">21</xref>
###xml 424 427 405 408 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 431 432 409 410 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 458 460 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib22">22</xref>
###xml 773 775 743 745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib23">23</xref>
PLCgamma2 is also activated by integrins but its role in integrin signal transduction is also controversial. Although a statistically significant decrease of spreading was reported in PLCgamma2-/- platelets (21, 22), that difference only accounted for a 30% reduction of the alpha2beta1 integrin-induced increase in cell surface area (21) or a delayed kinetics and moderately smaller percentage of full spreading on an alphaIIbbeta3 integrin ligand surface (22). Hence, PLCgamma2 appears to be a modulator rather than a critical component of integrin signaling in platelets. In contrast, a recent study focusing on the role of Vav family proteins in neutrophils suggested that PLCgamma2 downstream of Vav may be more directly involved in integrin signaling in these cells (23).
###end p 6
###begin p 7
###xml 111 113 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib24">24</xref>
###xml 423 425 411 413 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 861 863 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 93 98 <span type="species:ncbi:9606">human</span>
###xml 567 572 <span type="species:ncbi:10090">mouse</span>
###xml 711 716 <span type="species:ncbi:9606">human</span>
###xml 757 761 <span type="species:ncbi:10090">mice</span>
###xml 828 832 <span type="species:ncbi:10090">mice</span>
Rheumatoid arthritis is a severe chronic autoimmune disease affecting approximately1% of the human population (24). The disease is initiated by the emergence of autoreactive T cells (initiation or immunization phase), which then trigger the second (effector or tissue destruction) phase, mediated in large part by cells of the innate immune system. These two phases are very clearly separated in the K/BxN arthritis model (25). This model is initiated by a transgenic autoreactive T cell receptor (KRN transgene) on the autoimmunity-prone MHC background from the NOD mouse strain. This initial phase leads to the generation of autoantibodies that trigger excessive joint inflammation and destruction resembling human rheumatoid arthritis. Serum of affected mice can trigger the effector phase of the disease in otherwise normal mice (serum transfer arthritis) (26), allowing a clear separation of the two phases of the disease.
###end p 7
###begin p 8
###xml 173 175 173 175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 219 221 219 221 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 222 224 222 224 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib29">29</xref>
###xml 236 238 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib30">30</xref>
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib31">31</xref>
###xml 281 283 281 283 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 285 287 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">33</xref>
Analysis of the K/BxN and other models of autoimmune arthritis revealed that innate immune mechanisms are of critical importance in the later effector phase of the disease (26). Several studies using lineage depletion (27-29), genetic (30, 31), or combined genetic/reconstitution (32, 33) approaches indicate that neutrophils play a critical role in the effector phase of various animal models of autoimmune arthritis. However, the molecular mechanisms of how neutrophils contribute to the disease are very poorly understood.
###end p 8
###begin p 9
###xml 191 193 179 181 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 194 196 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">43</xref>
###xml 228 229 213 214 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 247 249 232 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 251 253 236 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">45</xref>
###xml 109 113 <span type="species:ncbi:10090">mice</span>
Several cell surface receptors have been shown to be involved in the pathogenesis of autoimmune arthritis in mice. These receptors include Fcgamma receptors such as FcgammaRIII or FcgammaRI (34-43) as well as members of the beta2 integrin family (44, 45). However, it is at present unclear how (e.g., through what intracellular signaling mechanisms) Fc receptors and integrins participate in the development of joint inflammation.
###end p 9
###begin p 10
The aforementioned results prompted us to test the role of PLCgamma2 in various in vitro neutrophil functions as well as in the development of neutrophil-mediated autoimmune arthritis in vivo. Our results indicate that PLCgamma2 is critically involved in integrin and Fc receptor-mediated neutrophil functions as well as in the neutrophil-mediated effector phase of autoimmune arthritis.
###end p 10
###begin title 11
RESULTS
###end title 11
###begin title 12
PLCgamma2 is the dominant PLCgamma isoform and is phosphorylated downstream of Src family kinases and Syk in neutrophils
###end title 12
###begin p 13
###xml 139 147 135 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 A</xref>
###xml 858 859 824 825 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 895 896 855 856 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 908 909 868 869 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 1094 1097 1030 1033 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1111 1119 1047 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 B</xref>
###xml 1176 1179 1104 1107 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 200 206 <span type="species:ncbi:10090">murine</span>
###xml 790 795 <span type="species:ncbi:10090">mouse</span>
First, we tested the expression level of the two PLCgamma isoforms in neutrophils and compared it to that in other cell types. As shown in Fig. 1 A, PLCgamma2 was expressed at comparable levels in WT murine neutrophils and splenocytes but at much lower levels in WT thymocytes. In contrast, PLCgamma1 was expressed in neutrophils at a much lower level than in the thymus or the spleen. Although these results suggested that PLCgamma2 is the predominant PLCgamma isoform in neutrophils, they did not allow the quantitative assessment of the relative expression of the two proteins in these cells. Hence, the expression of PLCgamma1 and PLCgamma2 was titrated against known amounts of recombinant Myc-tagged versions of the two proteins (Fig. S1 A, available at ). Based on those studies, WT mouse neutrophils were estimated to contain 53 +/- 26 ng PLCgamma2 (n = 3) and 3.0 +/- 1.2 ng PLCgamma1 (n = 3) per 106 cells, indicating that the expression of PLCgamma2 is approximately18-fold higher than that of PLCgamma1 in these cells. The expression of the two isoforms was also tested in PLCgamma2-/- neutrophils (Fig. 1 B). Although no PLCgamma2 signal was observed in PLCgamma2-/- cells, the expression of PLCgamma1 was not affected by the same mutation. The specificity of the antibodies used was also confirmed by the blocking effect of isoform-specific PLCgamma-blocking peptides (Fig. S1 B). Collectively, these results indicate than neutrophils express both PLCgamma1 and PLCgamma2, although PLCgamma2 is the predominant isoform. Furthermore, the genetic deficiency of PLCgamma2 does not affect the expression of PLCgamma1 in these cells.
###end p 13
###begin p 14
###xml 0 54 0 50 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression and activation of PLC&#947;2 in neutrophils.</bold>
###xml 230 233 206 209 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 330 333 298 301 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 336 339 304 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 342 345 310 313 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 369 372 337 340 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Expression and activation of PLCgamma2 in neutrophils. (A) Expression of PLCgamma2 and PLCgamma1 in WT neutrophils compared with WT thymocytes and splenocytes. (B) Analysis of PLCgamma1 and PLCgamma2 expression in WT and PLCgamma2-/- (PLCgamma2 KO) neutrophils. (C and D) PLCgamma2 phosphorylation in WT, Src family-deficient (Hck-/-Fgr-/-Lyn-/-; Src-family KO), or Syk-/- (Syk KO) neutrophils plated on a polyvalent integrin ligand (poly-RGD)-coated surface (pRGD) or left in suspension (control). PLCgamma2 phosphorylation was tested by immunoprecipitation (IP) followed by immunoblotting with antibodies against phosphotyrosine (PY). (E and F) Phosphorylation of PLCgamma2 in neutrophils of the various genotypes plated on an IgG immune complex-coated (IC) or control-treated surface. Immunoblotting for actin (A and B) and PLCgamma2 (C-F) served as loading controls. Molecular mass values represent the estimated apparent molecular mass of the proteins. Each panel represents three to five independent experiments with similar results.
###end p 14
###begin p 15
###xml 45 46 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 163 164 160 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib8">8</xref>
###xml 165 167 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 194 196 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 359 375 352 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 (C and D)</xref>
###xml 452 454 445 447 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 609 617 598 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 C</xref>
###xml 647 655 636 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 D</xref>
###xml 798 800 779 781 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">46</xref>
###xml 914 930 895 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 (E and F)</xref>
###xml 1068 1076 1045 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 E</xref>
###xml 1096 1104 1073 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig1">Fig. 1 F</xref>
###xml 658 664 <span type="species:ncbi:10090">Murine</span>
We and others have previously shown that beta2 integrins signal through a receptor-proximal tyrosine phosphorylation cascade involving Src family kinases and Syk (8-11; for review see reference 16). Next, we tested whether PLCgamma2 is also phosphorylated under these conditions and whether Src family kinases and Syk participate in this process. As shown in Fig. 1 (C and D), plating WT neutrophils on a polyvalent integrin ligand surface (poly-RGD) (11) triggered phosphorylation of PLCgamma2. Importantly, this phosphorylation response was absent in cells lacking the Src family kinases Hck, Fgr, and Lyn (Fig. 1 C) or the Syk tyrosine kinase (Fig. 1 D). Murine neutrophils can also be activated in an FcgammaRIII/FcgammaRIV-dependent manner by plating them on immobilized IgG immune complexes (46), leading to cellular responses that are dependent on Src family kinases and Syk (unpublished data). As shown in Fig. 1 (E and F), neutrophil activation by such immobilized immune complexes leads to phosphorylation of PLCgamma2 in WT but not in Src family-deficient (Fig. 1 E) or Syk-deficient (Fig. 1 F) neutrophils. These results suggest that PLCgamma2 is a downstream target of Src family kinases and Syk during both integrin and Fc receptor-mediated activation of neutrophils.
###end p 15
###begin title 16
###xml 9 12 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
PLCgamma2-/- bone marrow chimeras and neutrophil surface marker expression
###end title 16
###begin p 17
###xml 233 236 225 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 285 288 273 276 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 366 369 350 353 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 488 491 468 471 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 503 506 479 482 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 548 551 520 523 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 629 632 597 600 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 729 731 697 699 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib47">47</xref>
###xml 763 766 731 734 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 774 777 742 745 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 784 786 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib48">48</xref>
###xml 894 897 858 861 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1089 1092 1049 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1442 1443 1400 1401 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1470 1471 1426 1427 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1530 1533 1482 1485 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1825 1828 1773 1776 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 237 241 <span type="species:ncbi:10090">mice</span>
###xml 778 782 <span type="species:ncbi:10090">mice</span>
###xml 873 877 <span type="species:ncbi:10090">mice</span>
###xml 943 947 <span type="species:ncbi:10090">mice</span>
###xml 1693 1697 <span type="species:ncbi:10090">mice</span>
Our next aim was to test the role of PLCgamma2 in functional responses of neutrophils, using cells that are genetically deficient of this phospholipase isoform. Because we (and others) have not been able to breed homozygous PLCgamma2-/- mice (indicating a fertility defect in PLCgamma2-/- males and/or females), the mutation was maintained in heterozygous (PLCgamma2+/-) form. Even under such conditions, only 12% (rather than the expected 25%) of a total of 379 offsprings from PLCgamma2+/- x PLCgamma2+/- matings were found to be of the PLCgamma2-/- genotype at weaning age, indicating a partial defect in survival of PLCgamma2-/- embryos or newborn pups, which is likely a result of a lymphatic vascular developmental defect (47) similar to that seen in SLP-76-/- and Syk-/- mice (48). To overcome this problem, bone marrow transplantation was used to generate chimeric mice with a PLCgamma2-/- hematopoietic system. To this end, recipient mice carrying the CD45.1 allele on the C57BL/6 genetic background were lethally irradiated and then injected intravenously with isolated PLCgamma2-/- or control C57BL/6 bone marrow cells (both donor strains carry the CD45.2 allele). Repopulation of the neutrophil compartment by donor-derived cells was confirmed by flow cytometric analysis of the donor-specific CD45.2 allele in peripheral blood leukocytes 4-5 wk after transplantation (Fig. S2, available at ). Using this approach, 99.3 +/- 1.6% (n = 120) and 99.1 +/- 2.4% (n = 135) of peripheral blood neutrophils of WT and PLCgamma2-/- bone marrow chimeras, respectively, were found to be of donor origin. Though quite laborious, this approach allowed us to significantly increase the number of mice available for our studies. Unless otherwise stated, all of the following experiments were performed using such WT and PLCgamma2-/- bone marrow chimeras.
###end p 17
###begin p 18
###xml 201 202 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 227 228 219 220 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 238 241 226 229 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 265 266 253 254 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 393 396 373 376 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 485 493 465 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 A</xref>
###xml 557 560 533 536 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 607 608 580 581 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 630 638 603 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 B</xref>
###xml 677 685 646 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 C</xref>
###xml 704 712 673 681 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 D</xref>
###xml 849 857 810 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 E</xref>
###xml 904 912 861 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig2">Fig. 2 F</xref>
###xml 258 263 <span type="species:ncbi:10090">mouse</span>
We next tested whether the deficiency of PLCgamma2 affected neutrophil development or expression of major cell surface receptors. Our bone marrow neutrophil isolation protocol yielded 12.1 +/- 3.3 x 106 WT and 12.4 +/- 4.8 x 106 PLCgamma2-/- neutrophils per mouse (n = 23; P = 0.62), indicating that the lack of PLCgamma2 did not cause a quantitative change in neutrophil production. PLCgamma2-/- neutrophils also expressed normal levels of the Gr1 granulocyte differentiation marker (Fig. 2 A) and the general leukocyte marker CD45 (Fig. S2). The PLCgamma2-/- mutation did not affect expression of the beta2 integrin chain CD18 (Fig. 2 B) or the alpha chains of LFA-1 (CD11a; Fig. 2 C) or Mac-1 (CD11b; Fig. 2 D). There was no difference between the two genotypes in cell surface staining with a common FcgammaRII/FcgammaRIII-recognizing antibody (Fig. 2 E) or a monoclonal antibody against FcgammaRIV (Fig. 2 F). Collectively, genetic deficiency of PLCgamma2 did not affect neutrophil maturation or the expression of major cell surface integrins or Fcgamma receptors.
###end p 18
###begin p 19
###xml 49 52 45 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 65 0 61 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Expression of cell surface molecules on PLC&#947;2<sup>&#8722;/&#8722;</sup> neutrophils.</bold>
###xml 149 152 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Expression of cell surface molecules on PLCgamma2-/- neutrophils. Expression of the indicated cell surface molecules on unstimulated WT and PLCgamma2-/- (PLCgamma2 KO) bone marrow neutrophils was tested by flow cytometry. Each panel represents three to six independent experiments with similar results.
###end p 19
###begin title 20
PLCgamma2 is required for integrin and Fc receptor-mediated neutrophil functions
###end title 20
###begin p 21
###xml 292 294 288 290 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">49</xref>
###xml 444 445 437 438 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 472 474 465 467 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib50">50</xref>
###xml 486 488 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 517 525 510 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 A</xref>
###xml 562 565 551 554 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 809 812 794 797 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 855 858 836 839 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 934 942 915 923 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 B</xref>
###xml 983 991 964 972 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 C</xref>
###xml 1181 1182 1162 1163 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 1185 1186 1166 1167 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 1321 1329 1302 1310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 D</xref>
###xml 464 470 <span type="species:ncbi:9606">humans</span>
###xml 480 484 <span type="species:ncbi:10090">mice</span>
###xml 813 817 <span type="species:ncbi:10090">mice</span>
###xml 1290 1295 <span type="species:ncbi:10090">mouse</span>
###xml 1309 1314 <span type="species:ncbi:9606">human</span>
In the following experiments, the role of PLCgamma2 in in vitro neutrophil functions was investigated. Robust neutrophil activation can be achieved by plating the cells on an integrin ligand (e.g., fibrinogen)-coated surface in the presence of a soluble proinflammatory agonist, such as TNF (49), mimicking activation of neutrophils adherent to the extracellular matrix at the site of inflammation. This response is completely dependent on beta2 integrins both in humans (50) and mice (11) (see Fig. S4). As shown in Fig. 3 A, neutrophils obtained from PLCgamma2-/- bone marrow chimeras failed to produce superoxide when plated on a fibrinogen-coated surface in the presence of TNF. In a limited number of experiments, a similar defect was also seen in neutrophils isolated from intact (nonchimeric) PLCgamma2-/- mice (Fig. S3 A, available at ). PLCgamma2-/- neutrophils also failed to release the tertiary granule marker gelatinase (Fig. 3 B) or spread over the fibrinogen surface (Fig. 3 C) under identical conditions. A similar defect was seen when fibrinogen-adherent neutrophils were stimulated by other soluble proinflammatory agents, such as the TLR2 agonist lipopeptide Pam3CSK4, the TLR4-specific ligand ultrapurified LPS, the GM-CSF cytokine, or the MIP-2 chemokine, which is the mouse homologue of human IL-8 (Fig. 3 D), in a CD18-dependent manner (Fig. S4).
###end p 21
###begin p 22
###xml 66 69 62 65 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 82 0 78 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Defective integrin and Fc receptor-mediated responses of PLC&#947;2<sup>&#8722;/&#8722;</sup> neutrophils.</bold>
###xml 105 108 97 100 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 404 405 388 389 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 408 409 392 393 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 166 172 <span type="species:ncbi:10090">murine</span>
###xml 465 471 <span type="species:ncbi:10090">murine</span>
###xml 496 502 <span type="species:ncbi:10090">murine</span>
Defective integrin and Fc receptor-mediated responses of PLCgamma2-/- neutrophils. (A-C) WT and PLCgamma2-/- (PLCgamma2 KO) neutrophils were activated by 50 ng/ml of murine TNF on a fibrinogen (Fbg)-coated surface and the resulting superoxide production (A), gelatinase release (B), and cell spreading (C) followed. (D) Superoxide release of fibrinogen-adherent neutrophils activated with 1 microg/ml Pam3CSK4, 5 microg/ml of ultrapurified LPS (upLPS), 10 ng/ml of murine GM-CSF, or 100 ng/ml of murine MIP-2. (E and F) Superoxide release (E) and spreading (F) of neutrophils plated on a polyvalent integrin ligand (poly-RGD)-coated surface (pRGD) in the absence of any additional stimulus. (G-I) Superoxide release (G), degranulation (H), and spreading (I) of neutrophils plated on immobilized IgG immune complexes (IC). Unstimulated control values were subtracted in A, D, and G. Error bars represent SD of triplicate readings. Bars, 50 microm. Each panel is representative of three to five independent experiments with similar results.
###end p 22
###begin p 23
###xml 163 165 163 165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib49">49</xref>
###xml 167 169 167 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">51</xref>
###xml 176 177 173 174 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 388 390 385 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 402 405 395 398 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 489 497 482 490 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 E</xref>
###xml 574 582 567 575 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 F</xref>
Although both integrin ligation and a separate proinflammatory stimulus is required for maximal activation of adherent neutrophils under physiological conditions (49, 51), beta2 integrin-mediated in vitro neutrophil activation can also be achieved by plating the cells on surfaces coated with an engineered polyvalent integrin ligand (poly-RGD) in the absence of any additional stimulus (11). PLCgamma2-/- neutrophils failed to release superoxide when plated on a poly-RGD-coated surface (Fig. 3 E) and they did not spread on this polyvalent integrin ligand surface either (Fig. 3 F).
###end p 23
###begin p 24
###xml 223 226 215 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 254 260 246 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
Collectively, PLCgamma2 appears to be critically involved in the adhesion-dependent activation of neutrophils. Together with the fact that both TNF and the other soluble proinflammatory agonists signal normally in PLCgamma2-/- neutrophils in suspension (Fig. 4), our results indicate that PLCgamma2 is required for signaling by integrins rather than by receptors of the soluble proinflammatory agents.
###end p 24
###begin p 25
###xml 0 88 0 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLC&#947;2 is not required for integrin and Fc receptor-independent neutrophil functions.</bold>
###xml 131 134 123 126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 643 644 603 604 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 647 648 607 608 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 653 654 613 614 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 428 434 <span type="species:ncbi:10090">murine</span>
###xml 610 616 <span type="species:ncbi:10090">murine</span>
###xml 758 764 <span type="species:ncbi:10090">murine</span>
###xml 792 798 <span type="species:ncbi:10090">murine</span>
PLCgamma2 is not required for integrin and Fc receptor-independent neutrophil functions. (A) Superoxide release of WT and PLCgamma2-/- (PLCgamma2 KO) neutrophils stimulated with 100 nM PMA. (B and C) Superoxide production (B) and gelatinase release (C) triggered by 3 microM fMLP from neutrophils preincubated with 10 microM cytochalasin B (CB). (D) Up-regulation of CD18 and CD11b upon activation of neutrophils by 50 ng/ml of murine TNF in suspension. (E and F) Phosphorylation of the p38 MAP kinase (p38) and of Ikappa-Balpha and degradation of Ikappa-Balpha upon activation of neutrophils with 50 ng/ml of murine TNF (E) or 1 microg/ml Pam3CSK4 (Pam3; F). (G and H) Phosphorylation of ERK and the p38 MAP kinase upon neutrophil activation by 10 ng/ml of murine GM-CSF (G) or 100 ng/ml of murine MIP-2 (H). Molecular mass values represent the estimated apparent molecular mass of the proteins. Unstimulated controls were subtracted in A and B. Error bars represent SD of triplicate readings. Each panel is representative of three to four independent experiments with similar results.
###end p 25
###begin p 26
###xml 117 119 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">46</xref>
###xml 315 323 307 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 G</xref>
###xml 360 363 348 351 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 546 549 530 533 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 581 584 561 564 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 629 637 609 617 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 H</xref>
###xml 665 673 645 653 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3 I</xref>
###xml 550 554 <span type="species:ncbi:10090">mice</span>
Neutrophils can also be activated by immobilized IgG immune complexes in an FcgammaRIII/FcgammaRIV-dependent manner (46), mimicking their activation upon immune complex deposition in autoimmune diseases. Our unpublished observations indicate that this response also requires Src family kinases and Syk. As shown in Fig. 3 G, neutrophils isolated from PLCgamma2-/- bone marrow chimeras failed to release superoxide when plated on immobilized IgG immune complexes. Similar results were also obtained using neutrophils isolated from intact PLCgamma2-/- mice (Fig. S3 B). The PLCgamma2-/- mutation also abrogated gelatinase release (Fig. 3 H) and neutrophil spreading (Fig. 3 I) under such conditions. Hence, PLCgamma2 is also critically involved in Fcgamma receptor-mediated functional responses of neutrophils.
###end p 26
###begin title 27
PLCgamma2 is not required for signaling by G protein-coupled receptors, Toll-like receptors, and various cytokine receptors
###end title 27
###begin p 28
###xml 318 319 311 312 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 331 333 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 397 398 390 391 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib9">9</xref>
###xml 408 410 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 437 440 426 429 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 495 498 480 483 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 521 529 506 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 A</xref>
###xml 550 553 531 534 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 554 558 <span type="species:ncbi:10090">mice</span>
Next, we tested integrin and Fc receptor-independent responses in PLCgamma2-deficient neutrophils. As a first approach, the cells were stimulated with the nonphysiological protein kinase C-activating agent PMA, which is known to activate neutrophils even in the absence of important cell surface receptors such as beta2 integrins (11) or intracellular signaling molecules like Src family kinases (9) or Syk (11). PMA-stimulated PLCgamma2-/- neutrophils, which were isolated either from PLCgamma2-/- bone marrow chimeras (Fig. 4 A) or intact PLCgamma2-/- mice (Fig. S3 C), released normal amounts of superoxide, indicating that PLCgamma2 is not required for distal steps of NADPH oxidase activation.
###end p 28
###begin p 29
###xml 143 144 143 144 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 336 344 336 344 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 B</xref>
###xml 456 464 456 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 C</xref>
###xml 487 490 483 486 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 412 416 <span type="species:ncbi:10090">mice</span>
Robust integrin and Fc receptor-independent neutrophil activation can also be triggered by the bacterial formyl-peptide fMLP (which activates Gi protein-coupled receptors), especially if the cells are preincubated with the cytoskeletal disrupting agent cytochalasin B. Under such conditions, fMLP induced similar superoxide production (Fig. 4 B and Fig. S3 D for neutrophils from bone marrow chimeras and intact mice, respectively) and gelatinase release (Fig. 4 C) from WT and PLCgamma2-/- cells, indicating that PLCgamma2 is not required for formyl peptide receptor signal transduction.
###end p 29
###begin p 30
###xml 32 38 32 38 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 553 561 553 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 D</xref>
###xml 610 618 610 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 E</xref>
###xml 714 722 702 710 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 E</xref>
###xml 736 739 720 723 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 907 908 879 880 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 911 912 883 884 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 921 929 893 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 F</xref>
###xml 951 959 923 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 G</xref>
###xml 986 994 958 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4 H</xref>
###xml 1064 1067 1032 1035 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
In the experiments presented in Fig. 3, adhesion-dependent activation of neutrophils was tested in the presence of various soluble proinflammatory agonists. Because those agonists do not induce major functional responses (such as respiratory burst) in the absence of an integrin ligand surface (Fig. S4), their integrin-independent signaling capacity was assessed by testing up-regulation of cell surface integrins or activation of intracellular signaling pathways in suspension. TNF triggered normal up-regulation of the CD18 or CD11b integrin chains (Fig. 4 D), normal phosphorylation of the p38 MAP kinase (Fig. 4 E), and normal phosphorylation and degradation of the NF-kappaB pathway inhibitor Ikappa-Balpha (Fig. 4 E) in PLCgamma2-/- neutrophils. PLCgamma2 was not required for phosphorylation of p38 MAP kinase or phosphorylation/degradation of Ikappa-Balpha triggered by the TLR2-specific ligand Pam3CSK4 either (Fig. 4 F). Similarly, GM-CSF (Fig. 4 G) and the MIP-2 chemokine (Fig. 4 H) triggered normal ERK and p38 MAP kinase phosphorylation in PLCgamma2-/- neutrophils.
###end p 30
###begin p 31
###xml 210 213 202 205 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 227 233 219 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
Collectively, PLCgamma2 is not required for integrin and Fc receptor-independent functional and signaling responses of neutrophils. These results also suggest that the defective adherent activation of PLCgamma2-/- neutrophils (Fig. 3) is caused by a defect in integrin signaling rather than that of the soluble proinflammatory agonists.
###end p 31
###begin title 32
Normal migration of PLCgamma2-deficient neutrophils
###end title 32
###begin p 33
###xml 149 150 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 266 267 260 261 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 360 361 351 352 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 396 398 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 473 474 457 458 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Neutrophil migration to the site of inflammation is mediated by several cell surface receptors including chemokine/chemoattractant receptors and beta2 integrins. Our previous studies indicated that Src family kinases and Syk, which are indispensable for various beta2 integrin-dependent effector functions of neutrophils, are surprisingly not required for beta2 integrin-mediated cell migration (11). Those studies prompted us to test whether PLCgamma2 participates in beta2 integrin-mediated migration of neutrophils.
###end p 33
###begin p 34
###xml 240 248 232 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 A</xref>
###xml 316 317 305 306 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 329 331 318 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 396 397 378 379 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In an in vitro Transwell assay system, PLCgamma2-deficient neutrophils migrated as well as WT cells toward increasing concentrations of the bacterial tripeptide fMLP through a fibrinogen-coated polycarbonate membrane of 3-microm pore size (Fig. 5 A). Because neutrophil migration under these conditions requires beta2 integrins (11), these results indicate that PLCgamma2 is not required for beta2 integrin-mediated neutrophil migration in vitro.
###end p 34
###begin p 35
###xml 50 53 46 49 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 0 66 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Normal in vitro and in vivo migration of PLC&#947;2<sup>&#8722;/&#8722;</sup> neutrophils.</bold>
###xml 100 103 92 95 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 568 571 548 551 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1006 1009 982 985 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1165 1168 1137 1140 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 665 670 <span type="species:ncbi:10090">mouse</span>
###xml 875 880 <span type="species:ncbi:10090">mouse</span>
###xml 1181 1185 <span type="species:ncbi:10090">mice</span>
Normal in vitro and in vivo migration of PLCgamma2-/- neutrophils. (A) Migration of WT and PLCgamma2-/- (PLCgamma2 KO) neutrophils toward the indicated concentrations of fMLP through fibrinogen-coated transwell membranes of 3-microm pore size. Error bars represent SD of duplicate readings. Data are representative of three independent experiments. (B and C) Competitive migration of CD45.2-expressing and CD45.1-expressing neutrophils during thioglycollate-induced sterile peritonitis in mixed bone marrow chimeras. (B) Percentage of CD45.2-expressing WT or PLCgamma2-/- cells in the blood and the peritoneal lavage fluid. Each data point represents an individual mouse. The thin diagonal line marks points of identical percentage of CD45.2 cells in the blood and the peritoneum. Error bars represent SD from three blood samples taken at different time points from the same mouse. The data are combined from two independent experiments. (C) Relative migratory capacity of CD45.2-expressing WT or PLCgamma2-/- neutrophils relative to the CD45.1-expressing cells calculated from the data presented in B. Error bars represent SD of values from 6 (WT) or 18 (PLCgamma2-/-) individual mice.
###end p 35
###begin p 36
###xml 60 62 60 62 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 117 120 113 116 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 215 218 207 210 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 231 234 219 222 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 280 283 264 267 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 799 802 779 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 914 922 894 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 1052 1055 1028 1031 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1105 1108 1077 1080 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1155 1158 1123 1126 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1246 1254 1214 1222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 B</xref>
###xml 1362 1365 1326 1329 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1459 1462 1419 1422 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1470 1478 1430 1438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5 C</xref>
###xml 1563 1566 1523 1526 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1599 1601 1559 1561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
A competitive migration assay during a sterile peritonitis (11) was used to assess the in vivo migration of PLCgamma2-/- neutrophils. To this end, mixed bone marrow chimeras carrying both CD45.2-expressing PLCgamma2+/+ or PLCgamma2-/- cells, along with CD45.1-expressing PLCgamma2+/+ cells in their hematopoietic compartment, were generated. After the induction of a sterile peritonitis by intraperitoneal injection of sterile thioglycollate broth, the percentage of neutrophils from the two donor genotypes was determined both in the bloodstream and the peritoneal infiltrate. Any difference in this percentage between the two compartments would indicate different migratory capacities of neutrophils from the two donor strains. When both CD45.1- and CD45.2-expressing donor cells were of PLCgamma2+/+ genotype, the percentage of CD45.2-expressing neutrophils did not differ between the blood and the peritoneum (Fig. 5 B), indicating that the different alleles of CD45 do not affect neutrophil migration. In contrast, when CD45.2-expressing PLCgamma2-/- bone marrow cells and CD45.1-expressing PLCgamma2+/+ cells were present the percentage of PLCgamma2-/- cells in the inflamed peritoneum was consistently higher than that in the bloodstream (Fig. 5 B). Calculation of the relative migratory capacity of neutrophils revealed that the accumulation of PLCgamma2-/- neutrophils in the inflamed peritoneum was nearly twice more efficient than that of PLCgamma2+/+ cells (Fig. 5 C). These results are in sharp contrast with the severe reduction of migration of CD18-/- neutrophils in a similar assay (11). Therefore, in contrast to CD18, PLCgamma2 is not required for, or may even act as a negative regulator of, neutrophil migration into the inflamed peritoneum. Collectively, these results indicate that, similar to Src family kinases and Syk, PLCgamma2 is not required for CD18-dependent in vitro or in vivo migration of neutrophils.
###end p 36
###begin title 37
Leukocyte-endothelial interaction in fMLP-treated cremaster muscles in vivo
###end title 37
###begin p 38
###xml 253 260 249 256 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Figs. 3</xref>
###xml 265 266 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">5</xref>
###xml 486 489 478 481 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 678 681 666 669 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 773 776 753 756 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 824 832 804 812 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 A</xref>
###xml 1087 1090 1059 1062 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1101 1109 1073 1081 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 A</xref>
###xml 1289 1297 1261 1269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 B</xref>
###xml 1370 1373 1338 1341 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1417 1425 1385 1393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 B</xref>
###xml 1865 1868 1829 1832 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1891 1899 1855 1863 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 C</xref>
###xml 1961 1976 1925 1940 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6, A and B</xref>
###xml 2142 2145 2102 2105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 2228 2236 2188 2196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 D</xref>
To gain further insight into the relationship between spreading, adherent activation, and cell migration in neutrophils, as well as to exclude the possibility that the aforementioned differences between the role of PLCgamma2 in these processes (compare Figs. 3 and 5) stem from the very different assay systems used, we performed the simultaneous analysis of leukocyte adhesion, spreading, and extravasation in individual venules of fMLP-superfused cremaster muscles of WT and PLCgamma2-/- bone marrow chimeras. As shown in Table S1 (available at ), there was no difference in the various hemodynamic parameters or total leukocyte counts between the two genotypes. The PLCgamma2-/- mutation did not affect rolling flux fraction (36 +/- 11 and 28 +/- 12% in WT and PLCgamma2-/- chimeras, respectively) or leukocyte adhesion (Fig. 6 A) under resting conditions either. However, although local superfusion of the cremaster muscle of WT chimeras with 1 microM fMLP triggered a significant increase in stable adhesion of leukocytes to the vessel wall, no such effect was observed in PLCgamma2-/- chimeras (Fig. 6 A). fMLP also induced the spreading of WT leukocytes, as indicated by the flattening (decreased diameter perpendicular to the vessel wall) of the cells adherent to the endothelium (Fig. 6 B). This spreading (flattening) response was strongly reduced in PLCgamma2-/- bone marrow chimeras at early time points (Fig. 6 B), although the mutant cells were able to partially flatten down at later time points after fMLP stimulation. Besides these real-time in vivo microscopic observations, parallel cremaster muscle samples were subjected to whole mount histological analyses. Those studies again revealed that the fMLP-induced increase of the intravascular leukocyte count (an approximate measure of leukocyte adhesion) was significantly attenuated in PLCgamma2-/- bone marrow chimeras (Fig. 6 C), likely reflecting the described adhesion/spreading defect (Fig. 6, A and B). Despite all these observations, the fMLP-induced increase of the number of perivascular leukocytes (an approximate measure of leukocyte extravasation) in PLCgamma2-/- chimeras was similar to or even slightly higher than that in WT control chimeras (Fig. 6 D), suggesting that transendothelial migration of leukocytes was not impaired in the absence of PLCgamma2. These results again indicate that a defective adhesion/spreading response in the absence of PLCgamma2 does not translate into impaired migration of leukocytes through the vessel wall.
###end p 38
###begin p 39
###xml 0 83 0 83 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Leukocyte&#8211;endothelial interaction in fMLP-treated cremaster muscle venules in vivo.</bold>
###xml 256 259 248 251 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Leukocyte-endothelial interaction in fMLP-treated cremaster muscle venules in vivo. (A and B) Intravital microscopy of postcapillary cremaster muscle venules superfused with 1 microM fMLP. (A) Leukocyte adhesion in postcapillary venules of WT and PLCgamma2-/- (PLCgamma2 KO) bone marrow chimeras before (pre) and at the indicated time points during superfusion with fMLP. (B) Leukocyte spreading in fMLP-superfused cremaster muscle venules. The rate of spreading is expressed as the percent decrease in cell diameter perpendicular to the vessel wall. Mean and SEM of data obtained from four WT and five PLCgamma2 KO chimeras are shown. (C and D) Leukocyte adhesion (C) and extravasation (D) assessed by histological analysis of whole mount preparations of cremaster muscles of WT or PLCgamma2 KO bone marrow chimeras superfused for 15 min in the presence or absence of 1 microM fMLP. The mean and SEM are shown of the number of intravascular (C) and perivascular (D) leukocytes in 29-41 individual vessels per group from four WT and five PLCgamma2 KO chimeras, each tested independently during the same day.
###end p 39
###begin title 40
###xml 9 12 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
PLCgamma2-/- bone marrow chimeras are protected from macroscopic and microscopic signs of autoimmune arthritis
###end title 40
###begin p 41
###xml 444 446 436 438 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 448 450 440 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib32">32</xref>
###xml 452 454 444 446 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">33</xref>
###xml 487 488 476 477 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 500 502 489 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 527 529 512 514 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 530 532 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib41">41</xref>
The role of PLCgamma2 in integrin and Fc receptor-mediated neutrophil functions raise the possibility that PLCgamma2 may be involved in the pathogenesis of inflammatory diseases mediated by these factors. To test this possibility, we turned to the K/BxN serum transfer arthritis model, an autoantibody-mediated model of the effector phase of autoimmune arthritis. Prior studies from other groups indicated that this model requires neutrophils (27, 32, 33) as well as the presence of beta2 integrins (44) and Fcgamma receptors (34-41). We have also confirmed the latter two conclusions (unpublished data).
###end p 41
###begin p 42
###xml 92 93 84 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</italic>
###xml 90 93 82 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/<italic>&#8722;</italic></sup>
###xml 346 354 338 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 419 422 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 432 440 420 428 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 A</xref>
###xml 822 825 802 805 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 894 902 874 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 B</xref>
###xml 1014 1022 994 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 C</xref>
###xml 1097 1100 1073 1076 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1111 1119 1087 1095 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 C</xref>
###xml 881 886 <span type="species:ncbi:10090">mouse</span>
To test the role of PLCgamma2 in the K/BxN serum transfer arthritis model, WT or PLCgamma2-/- bone marrow chimeras were injected with arthritogenic K/BxN serum or normal serum from nonarthritic (KRN transgene negative) littermates. Although WT bone marrow chimeras injected with arthritogenic serum developed severe arthritis of their hind paws (Fig. 7 A), no sign of the disease was seen in similarly treated PLCgamma2-/-chimeras (Fig. 7 A), indicating a major role for PLCgamma2 in the development of K/BxN serum transfer arthritis. Quantification of arthritis severity by clinical scoring revealed that arthritis became evident 2 d after injection of WT chimeras with arthritogenic serum, peaked between 8-12 d, and started to cease afterward. Importantly, no signs of arthritis were seen at any time point in PLCgamma2-/- bone marrow chimeras injected with arthritogenic K/BxN mouse serum (Fig. 7 B). Treatment of WT chimeras with arthritogenic serum also triggered a robust increase of their ankle thickness (Fig. 7 C), whereas the same treatment had no effect on ankle thickness of PLCgamma2-/- chimeras (Fig. 7 C). Collectively, PLCgamma2 within the hematopoietic compartment is indispensable for the development of macroscopic signs of autoimmune arthritis in the K/BxN serum transfer model.
###end p 42
###begin p 43
###xml 0 76 0 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLC&#947;2 is required for the development of K/B&#215;N serum transfer arthritis.</bold>
###xml 93 96 85 88 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 169 173 <span type="species:ncbi:10090">mice</span>
###xml 175 178 <span type="species:ncbi:10090">D-F</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 603 607 <span type="species:ncbi:10090">mice</span>
###xml 806 809 <span type="species:ncbi:10090">D-F</span>
###xml 906 910 <span type="species:ncbi:10090">mice</span>
###xml 972 976 <span type="species:ncbi:10090">mice</span>
###xml 1081 1085 <span type="species:ncbi:10090">mice</span>
###xml 1145 1149 <span type="species:ncbi:10090">mice</span>
PLCgamma2 is required for the development of K/BxN serum transfer arthritis. WT and PLCgamma2-/- (PLCgamma2 KO) bone marrow chimeras (A-C and G) or intact (nonchimeric) mice (D-F) were injected with 400 microl of arthritic (K/BxN) or nonarthritic control serum and the development of arthritis followed. (A) Photographs of the hind limb of mice of the indicated treatment and hematopoietic genotype 10 d after serum injection. Pictures are representative of a total of 17-23 individual mice per group from eight independent experiments. (B and C) Hind limb clinical score (B) and ankle thickness (C) of mice of the indicated treatment and genotype. Error bars represent the SD of four to eight individual clinical scores or ankle thickness values from a single experiment repeated a total of eight times. (D-F) Hind limb photographs (D), clinical score (E), and ankle thickness (F) of intact (nonchimeric) mice of the indicated treatment and genotype. Data are from three mice per group tested in parallel. Error bars represent the SD of six individual hind limb values from three mice per group. (G) Histological analysis of the ankle joint of mice of the indicated treatment and hematopoietic genotype 4 d after serum injection. The photomicrographs on the right are enlarged from the highlighted areas in the middle pictures. Original magnification, 5x. Bars: (left and middle) 200 microm; (right) 100 microm. Photomicrographs are representative of a total of four to six samples per group from three independent experiments.
###end p 43
###begin p 44
###xml 209 211 209 211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib52">52</xref>
###xml 308 311 304 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 330 342 326 338 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 (D&#8211;F)</xref>
###xml 312 316 <span type="species:ncbi:10090">mice</span>
###xml 338 341 <span type="species:ncbi:10090">D-F</span>
To exclude the possibility that these results were affected by the bone marrow transplantation approach (e.g., by the use of irradiation that by itself may affect the course of autoimmune arthritis [reference 52]), the same experiments were repeated on a small cohort of intact (nonchimeric) WT and PLCgamma2-/- mice. As shown in Fig. 7 (D-F), genetic deficiency of PLCgamma2 completely abrogated the development of all clinical signs of K/BxN serum transfer arthritis even in such nonchimeric animals.
###end p 44
###begin p 45
###xml 131 139 131 139 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 G</xref>
###xml 389 392 385 388 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 449 457 445 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 G</xref>
We also performed histological analysis of the ankle joint of bone marrow chimeras of the various experimental groups. As shown in Fig. 7 G, a robust leukocytic infiltration of the periarticular tissues could be observed in WT chimeras injected with arthritogenic serum relative to those injected with nonarthritogenic control serum. Importantly, no such infiltration was seen in PLCgamma2-/- bone marrow chimeras injected with arthritogenic serum (Fig. 7 G), indicating that PLCgamma2 is required for the development of microscopic signs of arthritis such as the accumulation of leukocytes in the periarticular space.
###end p 45
###begin title 46
###xml 9 12 5 8 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
PLCgamma2-/- bone marrow chimeras are protected from arthritis-induced loss of articular function
###end title 46
###begin p 47
###xml 303 311 303 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8 A</xref>
###xml 616 619 612 615 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 755 763 751 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8 A</xref>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
Besides the macroscopic and microscopic signs of inflammation, arthritis also leads to severe impairment of articular function. This was assessed by testing the ability of the mice to hold on to the bottom of a horizontal wire grid similar to a regular wire cage lid. As shown in the video snapshots in Fig. 8 A, although WT chimeras injected with control serum were able to hold on to the wire grid for the entire 20-s assay period, WT chimeras injected with arthritogenic serum were not able to hold on for more than a few seconds, indicating an arthritis-induced loss of articular function. Importantly, PLCgamma2-/- bone marrow chimeras injected with arthritogenic serum had no difficulties in holding on to the wire grid for the entire assay period (Fig. 8 A).
###end p 47
###begin p 48
###xml 0 80 0 76 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLC&#947;2 deficiency protects from arthritis-induced loss of articular function.</bold>
###xml 97 100 89 92 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 171 175 <span type="species:ncbi:10090">mice</span>
###xml 300 304 <span type="species:ncbi:10090">mice</span>
###xml 386 390 <span type="species:ncbi:10090">mice</span>
###xml 522 526 <span type="species:ncbi:10090">mice</span>
###xml 697 701 <span type="species:ncbi:10090">mice</span>
###xml 1115 1120 <span type="species:ncbi:10090">mouse</span>
###xml 1225 1229 <span type="species:ncbi:10090">mice</span>
###xml 1380 1385 <span type="species:ncbi:10090">mouse</span>
PLCgamma2 deficiency protects from arthritis-induced loss of articular function. WT and PLCgamma2-/- (PLCgamma2 KO) bone marrow chimeras (A and B) or intact (nonchimeric) mice (C) were injected with 400 microl of arthritic (K/BxN) or nonarthritic control serum. 6-12 d after the serum injection, the mice were placed on a custom-made wire grid, flipped over, and the time for which the mice were able to hold on to the lower side of the grid was recorded. (A) Snapshots at the indicated time points from video captures of mice of the indicated treatment and hematopoietic genotype 10 d after serum injection. The snapshots are representative of a total of 165-263 individual measurements on 10-16 mice per group from four independent experiments. (B) Quantitative analysis of the articular function as represented by the percentage of the bone marrow chimeras from a given group to hold on to the grid for a given period of time after the grid has been flipped over from four independent experiments. Error bars represent SEM of 10-16 individual "holding on curves" (obtained from 12-21 measurements on each single mouse between 8 and 12 d after serum transfer). (C) Quantitative analysis of the articular function of intact mice of the indicated treatment and genotype. Error bars represent SEM of three individual holding on curves (obtained from 18 measurements on each single mouse between 8 and 12 d after serum transfer).
###end p 48
###begin p 49
###xml 320 328 320 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8 B</xref>
###xml 343 351 343 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8 B</xref>
###xml 614 622 614 622 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8 B</xref>
###xml 659 662 655 658 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 817 825 813 821 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8 B</xref>
###xml 972 975 964 967 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 982 990 974 982 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">Fig. 8 C</xref>
###xml 122 127 <span type="species:ncbi:10090">mouse</span>
###xml 191 195 <span type="species:ncbi:10090">mice</span>
###xml 976 980 <span type="species:ncbi:10090">mice</span>
###xml 1147 1151 <span type="species:ncbi:10090">mice</span>
To obtain a more quantitative assessment of joint function, this experiment was repeated several times on each individual mouse during the plateau phase of the disease, and the percentage of mice that were still holding on to the wire grid at a given time point was calculated analogous to Kaplan-Meier survival curves (Fig. 8 B). As shown in Fig. 8 B, nearly 90% of control-treated WT chimeras held on to the wire grid until the end of the 20-s assay period. In contrast, only 40% of WT chimeras injected with arthritogenic serum held on for >1 s, and practically none of them did so for the entire assay period (Fig. 8 B). Importantly, most of the PLCgamma2-/- chimeras were able to hold on to the wire grid for the entire 20-s period irrespective of whether they were injected with arthritogenic or control serum (Fig. 8 B). In a small set of experiments, a similar protection from arthritis-induced loss of articular function was seen in intact (nonchimeric) PLCgamma2-/- mice (Fig. 8 C), indicating that the effect of PLCgamma2 deficiency on articular function was not affected by the bone marrow transplantation approach used. Collectively, mice lacking PLCgamma2 are also protected from arthritis-induced loss of articular function.
###end p 49
###begin title 50
DISCUSSION
###end title 50
###begin p 51
###xml 82 87 <span type="species:ncbi:9606">human</span>
Rheumatoid arthritis is a severe chronic disease affecting approximately1% of the human population. Although the therapy of the disease has significantly improved during the last decades, it is still far from being solved. This is exemplified by the still widespread use of the highly cytotoxic chemotherapeutic agent methotrexate, the severe cardiovascular complications of COX-2 inhibitors, or the tremendous costs and possible side effects (e.g., reactivation of silent tuberculosis) of anti-TNF therapeutics. Better understanding of rheumatoid arthritis at the molecular level would strongly facilitate the development of novel treatment strategies for the disease.
###end p 51
###begin p 52
###xml 383 385 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib26">26</xref>
###xml 447 454 443 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Figs. 7</xref>
###xml 459 460 455 456 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig8">8</xref>
###xml 599 602 587 590 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 637 640 621 624 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 337 342 <span type="species:ncbi:10090">mouse</span>
The experiments presented in this paper provide evidence for the role of PLCgamma2 in the K/BxN arthritis model, one of the most widely used animal models of rheumatoid arthritis. A unique feature of this model is that its effector phase can be clearly separated from its initiation phase by transferring the serum of an arthritic K/BxN mouse to an otherwise nonarthritic recipient (26). Our experiments performed using this serum transfer model (Figs. 7 and 8) indicate that PLCgamma2 participates in the effector phase of the disease. Furthermore, the fact that bone marrow chimeras with PLCgamma2-/- hematopoietic system but PLCgamma2+/+ nonhematopoietic tissues are protected from K/BxN serum transfer arthritis indicates that PLCgamma2 within the hematopoietic system is indispensable for disease development.
###end p 52
###begin p 53
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib27">27</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib33">33</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib53">53</xref>
###xml 580 582 580 582 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib54">54</xref>
###xml 737 739 737 739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib55">55</xref>
###xml 879 881 879 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib56">56</xref>
###xml 1355 1357 1339 1341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib57">57</xref>
###xml 1359 1361 1343 1345 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib58">58</xref>
###xml 1570 1573 1550 1553 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
The effector phase of rheumatoid arthritis is mediated by several cell types, likely including various phagocytic lineages. To our knowledge, of those lineages only neutrophils have been consistently linked to the development of the inflammatory process in a diverse array of arthritis models and experimental approaches (27-33). Of the other phagocytes, liposome-mediated depletion studies suggested a pathogenetic role for macrophages (53), but another genetic study indicated that certain macrophage subsets play a negative rather than a positive role in autoimmune arthritis (54). Although an elegant series of genetic and reconstitution studies indicated the role of mast cells in the development of K/BxN serum transfer arthritis (55), another study using a different genetic approach suggested that arthritis development may proceed normally in the absence of mast cells (56). Based on these results, the most likely explanation for our in vivo results is that PLCgamma2 within neutrophils is required for the autoantibody-induced inflammation process. The second most likely PLCgamma2-dependent compartment would be the mast cell lineage, which also expresses PLCgamma2 and may be activated through integrins and Fcgamma receptors. However, because mast cells are long-lived radioresistant cells that survive a lethal irradiation in most tissues (57, 58), it is unlikely that our bone marrow transplantation approach was able to replace the majority of the recipients' mast cells. Hence, it unlikely that the complete defect of arthritis development in PLCgamma2-/- bone marrow chimeras is caused solely by the deficiency of PLCgamma2 in mast cells.
###end p 53
###begin p 54
###xml 181 183 177 179 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib34">34</xref>
###xml 184 186 180 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib37">37</xref>
###xml 246 248 234 236 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib36">36</xref>
###xml 249 251 237 239 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib42">42</xref>
###xml 341 343 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib43">43</xref>
###xml 362 363 343 344 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 375 377 356 358 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 406 408 387 389 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib44">44</xref>
###xml 410 412 391 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib45">45</xref>
###xml 132 136 <span type="species:ncbi:10090">mice</span>
Several cell surface receptors have also been shown to participate in various models of autoimmune arthritis. Several studies using mice lacking the Fc receptor common gamma chain (34-37) or Fcgamma receptor-specific ligand binding alpha chains (36-42) indicated a critical role for Fcgamma receptors in various autoimmune arthritis models (43). The role of beta2 integrins (44) or their putative ligands (44, 45) has also been shown in various autoimmune arthritis models. Somewhat surprisingly, however, there is very little information available on whether and to what extent signaling molecules downstream of these receptors play a role in the development of autoimmune arthritis. In this context, it is particularly important that our study identifies PLCgamma2, a component of integrin and Fc receptor signal transduction, as a critical player of the effector phase of autoimmune arthritis.
###end p 54
###begin p 55
###xml 139 140 139 140 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib1">1</xref>
###xml 141 142 141 142 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib3">3</xref>
###xml 144 145 144 145 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib5">5</xref>
###xml 561 562 561 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 563 565 563 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 592 594 592 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 745 751 741 747 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 926 927 918 919 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib6">6</xref>
###xml 928 930 920 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 932 934 924 926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib59">59</xref>
###xml 935 937 927 929 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib61">61</xref>
###xml 964 966 956 958 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib16">16</xref>
###xml 1233 1239 1221 1227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig4">Fig. 4</xref>
Neutrophils are critical players of the innate immune response but they also participate in tissue destruction during autoimmune diseases (1-3, 5). Integrins and Fc receptors are two major groups of cell surface receptors participating in neutrophil activation at the site of inflammation or bacterial invasion. We and others have shown that integrin and Fc receptor signaling in neutrophils are both mediated by a receptor-proximal tyrosine phosphorylation cascade consisting of Src family kinases, ITAM-bearing adaptor molecules, and the Syk tyrosine kinase (6-11; for review see reference 16) (unpublished data). In the present work, we identify PLCgamma2 as a common downstream mediator of integrin and Fc receptor signaling in neutrophils (Fig. 3). PLCgamma2 thus appears to be a new member of a growing family of intracellular molecules participating in both integrin and Fc receptor signal transduction in these cells (6-11, 59-61; for review see reference 16). In contrast, PLCgamma2 is dispensable for neutrophil activation through several other cell surface receptors such as G protein-coupled formyl peptide or chemokine receptors, various cytokine receptors (TNF and GM-CSF), or members of the Toll-like receptor family (Fig. 4). Hence, PLCgamma2 plays a specific role in signaling by a defined subset of neutrophil activatory receptors.
###end p 55
###begin p 56
###xml 92 93 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 261 267 254 260 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig3">Fig. 3</xref>
###xml 274 275 264 265 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 295 297 285 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 359 365 345 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Fig. 5</xref>
###xml 463 465 449 451 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 473 475 459 461 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 501 503 487 489 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 536 538 522 524 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib60">60</xref>
###xml 573 575 559 561 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 593 594 576 577 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
In addition to participating in adhesion-dependent functional responses of neutrophils, beta2 integrins are also required for the migration of the cells to the site of inflammation. Somewhat surprisingly, although PLCgamma2 is required for the former response (Fig. 3), beta2 integrin-mediated (11) neutrophil migration can occur in the absence of PLCgamma2 (Fig. 5). This is, however, in line with the normal migration of neutrophils lacking Src family kinases (11), Syk (11), ITAM-bearing adapters (10), or members of the Vav family (60) under CD18-dependent conditions (11). Therefore, beta2 integrins likely use other PLCgamma2-independent pathways to support neutrophil migration to the site of inflammation.
###end p 56
###begin p 57
###xml 331 334 331 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 357 359 357 359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib62">62</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">63</xref>
###xml 574 577 570 573 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 671 686 667 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6, A and C</xref>
###xml 726 734 722 730 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 B</xref>
###xml 781 789 777 785 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">Fig. 6 D</xref>
It is also puzzling how and to what extent spreading and extravasation can be dissected at the cellular and molecular level, given the generally accepted view that spreading and firm leukocyte adhesion precedes the transmigration of leukocytes through the vessel wall. Our prior studies on leukocyte-endothelial interactions in Syk-/- bone marrow chimeras (62, 63) indicated that a significant level of extravasation is possible even when adhesion is severely reduced and leukocyte spreading over the endothelium is apparently completely absent. Similar studies on PLCgamma2-/- bone marrow chimeras presented in this paper also indicate that severely defective adhesion (Fig. 6, A and C), and decreased and delayed spreading (Fig. 6 B) do not necessarily hinder the extravasation (Fig. 6 D) of leukocytes. Hence, transmigration of leukocytes through the vessel wall is possible even if adhesion and spreading are severely defective. It is at present unclear how transendothelial migration occurs under these conditions. One possibility is that integrin-mediated spreading and firm adhesion simply coincide with concomitant transmigration without any major role of the former two processes in the latter one. Alternatively, spreading and adhesion may play dual roles by promoting transmigration, for example, through arresting the leukocytes at the site of inflammation, but also hindering it, for example, by holding leukocytes back by the adhesive process. If so, then a defective adhesion/spreading response would not have any major net effect on transmigration of leukocytes. Further studies will be required to reveal whether and how these or other mechanisms can explain transmigration of leukocytes when their spreading and/or adhesion responses are severely impaired.
###end p 57
###begin p 58
###xml 182 185 178 181 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 248 256 244 252 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig7">Fig. 7 G</xref>
###xml 301 304 293 296 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 341 348 333 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig5">Figs. 5</xref>
###xml 353 354 345 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="fig6">6</xref>
###xml 621 624 605 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
Along the same line of thinking, it is also interesting to note that our histological analyses showed a complete lack of leukocytic infiltration in periarticular regions of PLCgamma2-/- bone marrow chimeras injected with arthritogenic K/BxN serum (Fig. 7 G). Based on the normal migration of PLCgamma2-/- neutrophils under other conditions (Figs. 5 and 6), we hypothesize that the lack of PLCgamma2 blocks the development of the inflammatory environment (chemokines, cytokines, and inflammatory endothelium). Hence, the otherwise migration-competent neutrophils are not attracted to the periarticular tissues in PLCgamma2-/- bone marrow chimeras.
###end p 58
###begin p 59
###xml 790 793 770 773 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 843 845 823 825 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib64">64</xref>
###xml 897 899 877 879 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib65">65</xref>
###xml 77 81 <span type="species:ncbi:10090">mice</span>
###xml 177 182 <span type="species:ncbi:10090">mouse</span>
All of the experiments presented in this paper have been performed on inbred mice on the C57BL/6 genetic background. This strain is the most widely used genetically homogeneous mouse strain, allowing the most accurate comparison of our results with those from other investigators. However, we cannot exclude the possibility that PLCgamma2 would be less critically involved in in vitro neutrophil functions and/or the effector phase of autoimmune arthritis on a different genetic background. Such a phenomenon could theoretically be possible through compensation by either PLCgamma1 or a PLCgamma-independent mechanism. Although it would be rather difficult to predict the possible extent of compensation by the latter mechanism, studies showing that overexpression of PLCgamma1 in PLCgamma2-/- cells was not able to restore B cell maturation (64) or the development of multinucleated osteoclasts (65) suggest that there is relatively little room for functional compensation between the two members of the PLCgamma family.
###end p 59
###begin p 60
###xml 309 312 301 304 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 624 627 608 611 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 996 998 976 978 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib66">66</xref>
###xml 1040 1042 1020 1022 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib67">67</xref>
###xml 1044 1046 1024 1026 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib68">68</xref>
###xml 1440 1443 1396 1399 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1523 1525 1479 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 968 973 <span type="species:ncbi:9606">human</span>
In addition to providing clear evidence for a role of PLCgamma2 in integrin-mediated neutrophil functions and the development of K/BxN serum transfer arthritis, our studies also raise several novel questions that have yet to be addressed in the future. Although we hypothesize that the effect of the PLCgamma2-/- mutation in vivo is a result of a neutrophil defect, this has yet to be confirmed more directly, for example, by lineage-specific deletion of PLCgamma2 in neutrophils. The same holds true for whether our in vivo phenotype is indeed caused by an integrin and/or Fc receptor signaling defect and whether PLCgamma2-/- neutrophils are indeed capable of migrating to the site of inflammation during a full-blown K/BxN serum transfer arthritis. Although our studies strongly implicate PLCgamma2 in the effector phase of autoantibody-mediated arthritis, its contribution to other aspects of the disease have yet to be tested, for example, using the TNF-mediated human TNF-transgenic Tg197 (66) or the IL-17-mediated SKG point mutant (67, 68) models. It is also unclear whether the lipase activity and/or other structural features of PLCgamma2 contribute to its role in neutrophil functions in vitro and arthritis development in vivo. This, and the reason for why PLCgamma1 is apparently not able to compensate for the lack of PLCgamma2, will need to be tested by reexpression of various PLCgamma2 mutants and/or PLCgamma1 in PLCgamma2-/- bone marrow cells, for example, by using a retroviral reconstitution strategy (10). Finally, the role of PLCgamma2 in the various aspects of antimicrobial functions of leukocytes (such as phagocytosis by myeloid lineage cells) and its relationship to that of Src family kinases and Syk has yet to be tested in more detail.
###end p 60
###begin p 61
###xml 595 600 <span type="species:ncbi:9606">human</span>
Collectively, we found that PLCgamma2 is a central component of integrin and Fc receptor signal transduction in neutrophils, linking the receptor-proximal Src family-ITAM adaptor-Syk cascade to functional responses of these cells. Our results also identify PLCgamma2 as a critical player of the effector phase of autoimmune arthritis, most likely through its role in integrin and Fc receptor signaling of neutrophils. These studies provide novel insight into the cellular and molecular mechanisms of autoimmune inflammation and may eventually point to novel targets of future therapies of major human diseases such as rheumatoid arthritis.
###end p 61
###begin title 62
MATERIALS AND METHODS
###end title 62
###begin title 63

###end title 63
###begin title 64
Animals.
###end title 64
###begin p 65
###xml 55 60 51 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PLCg2</italic>
###xml 60 66 56 62 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Jni</sup>
###xml 92 93 84 85 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 96 98 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib19">19</xref>
###xml 250 253 238 241 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 323 326 307 310 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 338 341 318 321 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8722;</sup>
###xml 645 648 625 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hck</italic>
###xml 648 661 628 641 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Hev/tm1Hev</sup>
###xml 661 664 641 644 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fgr</italic>
###xml 664 677 644 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Hev/tm1Hev</sup>
###xml 677 680 657 660 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Lyn</italic>
###xml 680 693 660 673 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Sor/tm1Sor</sup>
###xml 713 716 693 696 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 719 722 699 702 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 725 728 705 708 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 736 738 716 718 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib69">69</xref>
###xml 887 890 867 870 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Syk</italic>
###xml 890 896 870 876 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Tyb</sup>
###xml 907 909 887 889 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib70">70</xref>
###xml 934 935 914 915 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1039 1040 1019 1020 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;</sup>
###xml 1108 1111 1088 1091 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1180 1182 1160 1162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 1234 1236 1214 1216 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 1555 1557 1532 1534 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 1585 1590 1562 1567 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Itgb2</italic>
###xml 1590 1603 1567 1580 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm2Bay/tm2Bay</sup>
###xml 1624 1627 1601 1604 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1635 1637 1612 1614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib71">71</xref>
###xml 1747 1753 1720 1726 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Fcer1g</italic>
###xml 1753 1766 1726 1739 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">tm1Rav/tm1Rav</sup>
###xml 1791 1794 1760 1763 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1802 1804 1771 1773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib72">72</xref>
###xml 2130 2135 2099 2104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Ptprc</italic>
###xml 2135 2136 2104 2105 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">a</sup>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 137 145 <span type="species:ncbi:9606">Children</span>
###xml 254 258 <span type="species:ncbi:10090">mice</span>
###xml 730 734 <span type="species:ncbi:10090">mice</span>
###xml 869 873 <span type="species:ncbi:10090">Mice</span>
###xml 1185 1189 <span type="species:ncbi:10090">Mice</span>
###xml 1378 1382 <span type="species:ncbi:10090">mice</span>
###xml 1407 1411 <span type="species:ncbi:10090">mice</span>
###xml 1629 1633 <span type="species:ncbi:10090">mice</span>
###xml 1796 1800 <span type="species:ncbi:10090">mice</span>
###xml 1845 1849 <span type="species:ncbi:10090">mice</span>
###xml 1951 1955 <span type="species:ncbi:10090">mice</span>
###xml 2026 2030 <span type="species:ncbi:10090">mice</span>
###xml 2183 2187 <span type="species:ncbi:10090">Mice</span>
Heterozygous mice carrying a deleted PLCgamma2 allele (PLCg2tm1Jni, referred to as PLCgamma2-) (19) were obtained from J. Ihle (St. Jude Children's Research Hospital, Memphis, TN). Because of the limited fertility and survival of homozygous PLCgamma2-/- mice, the mutation was maintained in heterozygous form by a PLCgamma2+/- x PLCgamma2+/- breeding strategy. Offsprings were genotyped by allele-specific PCR reaction from tail DNA using 5'-GCCTCTGCACAGCACACATATGG-3' WT-specific and 5'-CAAGGTGAGATGACAGGAGATCC-3' mutant-specific forward primers along with the 5'-TTCACCGCATCCTCCTTTGAGTCC-3' common reverse primer. Triple Src family-deficient (Hcktm1Hev/tm1HevFgrtm1Hev/tm1HevLyntm1Sor/tm1Sor, referred to as Hck-/-Fgr-/-Lyn-/-) mice (69) were obtained from C. Lowell (University of California, San Francisco, San Francisco, CA) and kept as triple homozygous mutants. Mice carrying the Syktm1Tyb mutation (70) (referred to as the Syk- allele) were obtained from V. Tybulewicz (National Institute for Medical Research, London, UK). The Syk- mutation was maintained in heterozygous form and used to obtain Syk-/- neutrophils by fetal liver transplantation as previously described (11). Mice carrying the KRN T cell receptor transgene (25) were obtained from D. Mathis and C. Benoist (Harvard Medical School, Boston, MA) and maintained in heterozygous form by mating with C57BL/6 mice. KRN transgene-positive mice were identified by flow cytometry (see Flow cytometry) based on the high percentage of Vbeta6 TCR-expressing cells among CD4-positive T cells (25). Complete CD18-deficient (Itgb2tm2Bay/tm2Bay, referred to as CD18-/-) mice (71) were obtained from A. Beaudet (Baylor College of Medicine, Houston, TX). Fc receptor gamma chain-deficient (Fcer1gtm1Rav/tm1Rav, referred to as FcRgamma-/-) mice (72) were purchased from Taconic. All these mice were backcrossed to the C57BL/6 genetic background for eight or more generations. WT control C57BL/6 mice were purchased from the Hungarian National Institute of Oncology. NOD mice, as well as a congenic strain carrying the CD45.1 allele on the C57BL/6 genetic background (B6.SJL-Ptprca), were purchased from The Jackson Laboratory. Mice were kept in individually sterile ventilated cages (Tecniplast) in a conventional facility. All animal experiments were approved by the Semmelweis University (Budapest, Hungary) Animal Experimentation Review Board or the Regierungsprasidium Karlsruhe (Karlsruhe, Germany).
###end p 65
###begin p 66
###xml 45 48 41 44 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 184 186 180 182 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">60</sup>
###xml 323 326 315 318 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 349 353 <span type="species:ncbi:10090">mice</span>
###xml 403 408 <span type="species:ncbi:10090">mouse</span>
To obtain bone marrow chimeras with PLCgamma2-/- hematopoietic system, recipients carrying the CD45.1 allele on the C57BL/6 genetic background were lethally irradiated by 11 Gy from a 60Co source using an irradiator (Gammatron 3; Siemens) and then injected intravenously with unfractionated bone marrow cells from PLCgamma2-/- or WT C57BL/6 control mice. On average, bone marrow cells of a single donor mouse were injected into 10-12 recipients. 4-6 wk after transplantation, peripheral blood samples were stained for Gr1 and CD45.2 and analyzed by flow cytometry (see Flow cytometry). Repopulation of the hematopoietic compartment by donor-derived cells was defined as the percentage of CD45.2-positive (donor-derived) cells in the Gr1-positive granulocyte gate. Bone marrow chimeras were used 5-10 wk after the transplantation.
###end p 66
###begin title 67
Neutrophil isolation.
###end title 67
###begin p 68
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib73">73</xref>
###xml 326 328 326 328 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 336 338 336 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 0 5 <span type="species:ncbi:10090">Mouse</span>
Mouse neutrophils were isolated from the bone marrow of the femurs and tibias by hypotonic lysis followed by Percoll (GE Healthcare) gradient centrifugation as previously described (73). Neutrophil isolation was performed at room temperature using sterile and endotoxin-free reagents. Cells were kept at room temperature in Ca2+- and Mg2+-free medium until use (usually less <30 min) and prewarmed to 37degreesC before activation. Neutrophil assays were performed at 37degreesC in Hank's balanced salt solution (Invitrogen) supplemented with 20 mM Hepes, pH 7.4.
###end p 68
###begin title 69
Flow cytometry.
###end title 69
###begin p 70
###xml 400 402 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib74">74</xref>
###xml 440 444 <span type="species:ncbi:10090">mice</span>
###xml 642 645 <span type="species:ncbi:10116">rat</span>
For neutrophil studies, isolated neutrophils, peripheral blood samples, or peritoneal lavage fluids were stained with PE-conjugated anti-Gr1 (RB6-8C5), FITC-conjugated anti-CD45.2 (clone 104), biotinylated anti-CD11b (M1/70), or unconjugated antibodies against CD18 (C71/16), CD11a (M17/4), FcgammaRII/III (2.4G2), or FcgammaRIV (9E9; obtained from J. Ravetch, Rockefeller University, New York, NY) (74). To identify KRN transgene-positive mice, peripheral blood samples were labeled with FITC-conjugated anti-CD4 (RM4-5) and PE-conjugated anti-TCR Vbeta6 (RR4-7) antibodies. Unconjugated antibodies were visualized with FITC-conjugated anti-rat IgG whereas biotinylated anti-CD11b was visualized with streptavidin-Cy3 (Jackson ImmunoResearch Laboratories). Unless otherwise stated, all flow cytometry antibodies and their isotype controls were purchased from BD. All staining was performed in the presence of 2% FCS (Invitrogen). Samples were fixed in FACS Lysing Solution (BD) and analyzed on a FACSCalibur (BD) using CellQuest software (BD). Neutrophils and CD4-positive T cells were identified based on positive labeling for Gr1 and CD4, respectively, along with their typical forward- and side-scatter characteristics.
###end p 70
###begin title 71
In vitro functional assays.
###end title 71
###begin p 72
###xml 146 147 142 143 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 150 151 146 147 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 450 452 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 454 456 442 444 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 914 916 898 900 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">46</xref>
###xml 978 980 962 964 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 1029 1031 1013 1015 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 1033 1035 1017 1019 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 1037 1039 1021 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib73">73</xref>
###xml 1041 1043 1025 1027 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib75">75</xref>
###xml 59 65 <span type="species:ncbi:10090">murine</span>
###xml 107 113 <span type="species:ncbi:10090">murine</span>
###xml 246 252 <span type="species:ncbi:10090">murine</span>
###xml 301 307 <span type="species:ncbi:10090">murine</span>
###xml 391 396 <span type="species:ncbi:9606">human</span>
Adhesion-dependent activation was performed by stimulating murine neutrophils with 50 ng/ml of recombinant murine TNF (PeproTech), 1 microg/ml Pam3CSK4 (EMC Microcollections), 5 microg/ml of ultrapurified LPS (InvivoGen), 10 ng/ml of recombinant murine GM-CSF (PeproTech), or 100 ng/ml of recombinant murine MIP-2 (PeproTech) while adherent to a plastic surface coated with 150 microg/ml of human fibrinogen (MP Biomedicals) as previously described (10, 11). Integrin-mediated activation in the absence of another soluble stimulus was achieved by plating neutrophils on surfaces precoated with 20 microg/ml of engineered polyvalent integrin ligand peptide (poly-RGD; F5022; Sigma-Aldrich) Neutrophil activation by immobilized immune complexes was achieved by plating the cells on immobilized HSA-anti-HSA (both obtained from Sigma-Aldrich) immune complexes without any additional stimulus as previously described (46). Activation of neutrophils in suspension was performed in Mg2+-free media essentially as previously described (10, 11, 73, 75) using 100 nM PMA (Sigma-Aldrich), 3 microM fMLP (Sigma-Aldrich), or 50 ng/ml TNF. fMLP-stimulated cells were pretreated with 10 microM cytochalasin B (CB; Sigma-Aldrich) for 10 min before cell activation. Where necessary, the reaction was stopped after 10 min (degranulation triggered by CB+fMLP) or 30 min (integrin and Fc receptor-mediated degranulation and spreading responses; TNF-induced integrin up-regulation).
###end p 72
###begin p 73
###xml 60 61 60 61 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c</italic>
###xml 119 121 119 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib51">51</xref>
###xml 462 464 462 464 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 466 468 466 468 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib46">46</xref>
Superoxide release was determined by a real-time cytochrome c (Sigma-Aldrich) reduction test, as previously described (51), using a multiplate reader (Multiskan Ascent; Thermo Fisher Scientific) in dual wavelength (550 and 540 nm) kinetic measurement mode. To simplify the presentation, unstimulated control values were subtracted from those of stimulated samples. Exocytosis of gelatinase was determined by in-gel gelatinase zymography as previously described (10, 46). Cell spreading was assessed after formalin fixation using an inverted microscope (DMI 6000B; Leica) with a 20x phase-contrast objective connected to a charge-coupled device camera (DFC480; Leica).
###end p 73
###begin title 74
Biochemical and signaling studies.
###end title 74
###begin p 75
###xml 29 32 25 28 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 97 99 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 101 103 97 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib73">73</xref>
###xml 679 683 <span type="species:ncbi:10090">mice</span>
Unstimulated WT and PLCgamma2-/- neutrophils were lysed in a 1% Triton X-100-based lysis buffer (11, 73), and their Triton-soluble fraction were boiled in sample buffer, run on SDS-PAGE, and immunoblotted with antibodies against PLCgamma2 (Q-20; Santa Cruz Biotechnology, Inc.), PLCgamma1 (1249; Santa Cruz Biotechnology, Inc.), or beta-actin (AC-74; Sigma-Aldrich), followed by peroxidase-labeled secondary antibodies (GE Healthcare). Where indicated, primary antibodies were preincubated with 0.4 microg/ml of the relevant blocking peptides (Santa Cruz Biotechnology, Inc.) before incubation with the immunoblotting membrane. Lysates prepared from thymus or spleen cells of WT mice served for comparisons of signal intensity.
###end p 75
###begin p 76
###xml 199 201 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib76">76</xref>
###xml 32 37 <span type="species:ncbi:9606">human</span>
###xml 352 358 <span type="species:ncbi:10090">murine</span>
###xml 602 607 <span type="species:ncbi:9606">human</span>
###xml 612 618 <span type="species:ncbi:10090">murine</span>
###xml 870 875 <span type="species:ncbi:9606">human</span>
###xml 980 986 <span type="species:ncbi:10090">murine</span>
Purified recombinant Myc-tagged human PLCgamma1 and PLCgamma2, expressed in Sf9 insect cells using a baculoviral expression system, were obtained from P. Gierschik (University of Ulm, Ulm, Germany) (76). For the quantification (titration) of PLCgamma1 and PLCgamma2 expression in neutrophils, various amounts of the two recombinant proteins along with murine neutrophil lysates were run on SDS-PAGE and immunoblotted using the aforementioned PLCgamma1 and PLCgamma2 antibodies as well as an antibody against the Myc epitope (clone 9E10; Santa Cruz Biotechnology, Inc.). The amino acid sequences of the human and murine proteins are practically identical around the putative antibody recognition sites in the cases of both PLCgamma isoforms, whereas there is hardly any similarity between PLCgamma1 and PLCgamma2 at the same sites, which justifies the use of recombinant human PLCgamma isoforms along with the aforementioned polyclonal antibodies for the quantification of the two murine proteins.
###end p 76
###begin p 77
###xml 172 173 168 169 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
###xml 176 177 172 173 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
###xml 220 222 216 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2+</sup>
###xml 406 408 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 410 412 406 408 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib73">73</xref>
For biochemical signaling experiments, neutrophils were plated on a poly-RGD or immobilized immune complex surface, or they were stimulated by 50 ng/ml TNF, 1 microg/ml Pam3CSK4, 10 ng/ml GM-CSF, or 100 ng/ml MIP-2 in Mg2+-free media in suspension. After 3-min (MIP-2) or 10-min (all other stimuli) incubations, the reaction was stopped and cell lysates were prepared in a Triton X-100-based lysis buffer (11, 73), except for immunoprecipitation assays where the lysis buffer was supplemented with 0.1% SDS and 0.5% sodium deoxycholate (RIPA). PLCgamma2 was precipitated using the Q-20 PLCgamma2 antibody and captured using a 1:1 mixture of protein A Sepharose (Invitrogen) and protein G Agarose (Invitrogen). Triton-soluble whole-cell lysates or PLCgamma2 immunoprecipitates were immunoblotted with antibodies against phosphotyrosine (clone 4G10; Millipore), PLCgamma2, p38 MAP kinase (C-20; Santa Cruz Biotechnology, Inc.), ERK1/2 (combination of C-16 [ERK1] and C-14 [ERK2]; Santa Cruz Biotechnology, Inc.), Ikappa-Balpha (Cell Signaling Technology), or phosphospecific antibodies (Cell Signaling Technology) against the p38 MAP kinase, ERK, and Ikappa-Balpha (14D4).
###end p 77
###begin title 78
In vitro and in vivo migration.
###end title 78
###begin p 79
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib10">10</xref>
###xml 116 118 116 118 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 288 291 280 283 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 561 563 553 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 228 233 <span type="species:ncbi:9606">human</span>
###xml 292 298 <span type="species:ncbi:10090">murine</span>
In vitro migration of neutrophils was assessed by a Transwell assay system essentially as previously described (10, 11). In brief, Transwell inserts with polycarbonate filters of 3-microm pore size (Corning) were precoated with human fibrinogen, filled with suspensions of WT or PLCgamma2-/- murine neutrophils, and inserted in 24-well plate wells filled with assay media containing varying concentrations of fMLP. The migration of neutrophils into the lower compartment during a 60-min period was assessed by an acid phosphatase assay as previously described (11).
###end p 79
###begin p 80
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib11">11</xref>
###xml 188 191 184 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 631 634 623 626 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 666 669 654 657 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 840 843 824 827 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 979 982 959 962 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1536 1539 1512 1515 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 1552 1555 1524 1527 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 1610 1613 1578 1581 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/+</sup>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 314 318 <span type="species:ncbi:10090">mice</span>
###xml 547 551 <span type="species:ncbi:10090">mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
A competitive migration assay during sterile peritonitis in mixed bone marrow chimeras (11) was used to assess in vivo migration of neutrophils. To this end, bone marrow cells of PLCgamma2-/- mice on the C57BL/6 genetic background (i.e., carrying the CD45.2 allele) were mixed with bone marrow cells from congenic mice expressing CD45.1 on the C57BL/6 genetic background at varying ratios ranging from 10 to 70% of CD45.2-expressing cells. This mixed cell suspension was injected intravenously into lethally irradiated CD45.1-expressing recipient mice, giving rise to mixed bone marrow chimeras carrying CD45.2-expressing PLCgamma2-/- and CD45.1-expressing PLCgamma2+/+ hematopoietic cells. To exclude any effect of the different CD45 alleles on cell migration, a few control chimeras were generated in a similar fashion but using PLCgamma2+/+ (intact C57BL/6) mice as the CD45.2-expressing donor strain, giving rise to mixed chimeras with CD45.1- and CD45.2-expressing PLCgamma2+/+ hematopoietic cells. 5-8 wk after transplantation, the mixed bone marrow chimeras were injected intraperitoneally with 1 ml of 3% thioglycollate broth (Heipha Diagnostics). Blood was taken directly before as well as 2 and 4 h after the injection, and the peritoneal cavity was lavaged at 4 h. The relative percentage of CD45.1- and CD45.2-expressing neutrophils in the peripheral blood and peritoneal lavage samples was determined by flow cytometry in the Gr1-positive granulocyte gate. Relative migration of neutrophils of the CD45.2-positive PLCgamma2-/- or PLCgamma2+/+ genotypes (relative to the CD45.1-expressing PLCgamma2+/+ cells) was calculated as follows:
###end p 80
###begin title 81
Intravital microscopy and whole mount cremaster muscle preparation.
###end title 81
###begin p 82
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">63</xref>
###xml 553 555 549 551 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">63</xref>
Bone marrow chimeras were anesthetized using intraperitoneal injection of ketamine and xylazine and the cremaster muscle was prepared for intravital imaging as previously described (63). Intravital microscopy was performed on an upright microscope (BX51; Olympus) with a 40x 0.75 NA saline immersion objective. The microcirculation was recorded using a charge-coupled device camera (CF8/1; Kappa) coupled to a recorder (S-VHS; Panasonic). Superfusion of the cremaster muscle and local treatment with 1 microM fMLP was performed as previously described (63). Postcapillary venules ranged from 25 to 35 microm in diameter and were observed before and during fMLP administration.
###end p 82
###begin p 83
###xml 240 242 240 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib77">77</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">63</xref>
###xml 549 550 545 546 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">w</sub>
###xml 592 594 588 590 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">63</xref>
###xml 746 748 742 744 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib78">78</xref>
###xml 862 864 858 860 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">63</xref>
###xml 994 996 990 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib63">63</xref>
Geometric and hemodynamic parameters, such as vessel diameter, leukocyte diameter, and vessel segment length, of postcapillary venules were assessed from recorded video tapes using a digital image processing system as previously described (77). Spreading of adherent leukocytes in postcapillary venules was assessed by measuring the diameter (height) of attached leukocytes perpendicular to the vessel wall before and at various time points during fMLP superfusion as previously described (63). Mean blood flow velocities and wall shear rates (gammaw) were estimated as previously described (63). Rolling leukocyte flux fraction was defined as the ratio of rolling leukocytes to the total number of leukocytes passing the same vessel per minute (78). Leukocyte adhesion was defined as the number of adherent cells per millimeters squared of vessel surface area (63). Systemic leukocyte concentration was determined from blood samples taken at the end of the experiment as previously described (63).
###end p 83
###begin p 84
###xml 323 325 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib79">79</xref>
###xml 635 638 627 630 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 30 35 <span type="species:ncbi:10090">mouse</span>
###xml 817 821 <span type="species:ncbi:10090">mice</span>
For whole mount preparations, mouse cremaster muscles were surgically prepared, as described in the first paragraph of this section, and superfused with 1 microM fMLP in superfusion buffer for 15 min. Thereafter, cremaster muscles were fixed with 4% paraformaldehyde and whole mounts were prepared as previously described (79). Fixed cremaster muscles were stained with Giemsa and analyzed for the number of intravascular and perivascular leukocytes using an upright microscope (Axioskop; Carl Zeiss, Inc.) through a 100x 1.3 NA oil immersion objective. Whole mounts from untreated cremaster muscles prepared from both WT and PLCgamma2-/- bone marrow chimeras served as negative controls. All cremaster muscle experiments were independently assessed by two investigators blinded for the treatment and genotype of the mice.
###end p 84
###begin title 85
K/BxN serum transfer arthritis.
###end title 85
###begin p 86
###xml 49 51 49 51 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="bib25">25</xref>
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
###xml 107 111 <span type="species:ncbi:10090">mice</span>
###xml 206 210 <span type="species:ncbi:10090">mice</span>
###xml 396 400 <span type="species:ncbi:10090">mice</span>
###xml 499 503 <span type="species:ncbi:10090">mice</span>
Mice carrying the KRN T cell receptor transgene (25) on the C57BL/6 genetic background were mated with NOD mice to obtain KRN transgene-positive offsprings on the C57BL/6 x NOD F1 genetic background (K/BxN mice) as well as their transgene-negative (BxN) littermates. The presence of the transgene was determined by flow cytometry as well as by looking for visible signs of arthritis in the K/BxN mice. Blood was taken by retroorbital bleeding and sera from transgene-positive and transgene-negative mice were pooled separately.
###end p 86
###begin p 87
###xml 127 130 119 122 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 176 180 <span type="species:ncbi:10090">mice</span>
###xml 375 379 <span type="species:ncbi:10090">mice</span>
###xml 476 480 <span type="species:ncbi:10090">mice</span>
Arthritis was induced by intraperitoneal injection of 400 microl of arthritogenic (K/BxN) or control serum into WT or PLCgamma2-/- bone marrow chimeras or intact (nonchimeric) mice, followed by daily assessment of arthritis development for 2 wk. Visible clinical signs of arthritis were scored on a 0-10 scale by two investigators blinded for the origin and treatment of the mice. Ankle thickness was measured by a spring-loaded caliper (Kroeplin). For histological analysis, mice were killed 4 d after serum transfer and their ankle joints were fixed in formalin (Sigma-Aldrich). The joints were then decalcified, embedded in paraffin, sectioned, and stained with hematoxylin and eosin (Histopathology Llc.). Photomicrographs were taken on a microscope (DMI 6000B; Leica).
###end p 87
###begin p 88
###xml 30 34 <span type="species:ncbi:10090">mice</span>
###xml 238 242 <span type="species:ncbi:10090">mice</span>
To assess articular function, mice were placed on a custom-made wire grid (Charles River Laboratories) with identical wire thickness and spacing to a regular wire cage lid. The wire grid was flipped upside down and the length of time the mice held on to the grid was recorded. This test was performed three times daily during the period of 8-12 d after the serum injection. The obtained data were combined into holding-on curves similar to Kaplan-Meier survival curves.
###end p 88
###begin title 89
Online supplemental information.
###end title 89
###begin p 90
###xml 177 180 165 168 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 351 354 335 338 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;/&#8722;</sup>
###xml 355 359 <span type="species:ncbi:10090">mice</span>
Fig. S1 shows expression level of PLCgamma isoforms in neutrophils and provides detailed information about PLCgamma antibody specificity. Fig. S2 shows repopulation of PLCgamma2-/- bone marrow chimeras by donor-derived neutrophils after bone marrow transplantation. Fig. S3 shows functional responses of neutrophils from intact (nonchimeric) PLCgamma2-/- mice. Fig. S4 shows CD18-dependent activation of adherent neutrophils by various proinflammatory agonists. Table S1 shows hemodynamic and microvascular parameters in fMLP-stimulated cremaster muscle venules. Online supplemental material is available at .
###end p 90
###begin title 91
Supplementary Material
###end title 91
###begin title 92
[Supplemental Material Index]
###end title 92
###begin p 93
###xml 37 40 33 36 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 139 142 135 138 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 145 148 141 144 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 151 154 147 150 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 188 191 184 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8211;/&#8211;</sup>
###xml 227 230 223 226 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+/&#8211;</sup>
###xml 41 45 <span type="species:ncbi:10090">mice</span>
###xml 95 110 <span type="species:ncbi:10090">transgenic mice</span>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
We thank James Ihle for the PLCgamma2-/- mice; Diane Mathis and Christophe Benoist for the KRN transgenic mice; Clifford Lowell for the Hck-/-Fgr-/-Lyn-/- mice; Arthur Beaudet for the CD18-/- mice; Victor Tybulewicz for the Syk+/- carriers; Peter Gierschik for recombinant PLCgamma1 and PLCgamma2; Tamas Nemeth, David Gyori, and Arpad Mikesy for help with experiments; Melitta Weissinger and Susanne Bierschenk for expert technical assistance during the cremaster muscle experiments; and Anna Erdei, Erzsebet Ligeti, Jozsef Mandl, and Istvan Turai for access to equipment.
###end p 93
###begin p 94
This work was supported by the Hungarian Scientific Research Fund (OTKA T046409 to A. Mocsai), the Hungarian Office for Research and Technology (NKFP-A1-0069/2006 to A. Mocsai), the US National Institutes of Health (RO3 TW006831 to A. Mocsai) and the European Research Council (Starting Independent Investigator Grant No. 206283 to A. Mocsai). A. Mocsai was an International Senior Research Fellow of the Wellcome Trust and an EMBO/HHMI Scientist. Z. Jakus and A. Mocsai were recipients of Bolyai Research Fellowships from the Hungarian Academy of Sciences.
###end p 94
###begin p 95
The authors have no conflicting financial interests.
###end p 95
###begin article-title 96
Neutrophils and immunity: challenges and opportunities.
###end article-title 96
###begin article-title 97
Tissue destruction by neutrophils.
###end article-title 97
###begin article-title 98
Granulocyte colony-stimulating factor and neutrophils - forgotten mediators of inflammatory disease.
###end article-title 98
###begin article-title 99
Points of control in inflammation.
###end article-title 99
###begin article-title 100
Neutrophils: molecules, functions and pathophysiological aspects.
###end article-title 100
###begin article-title 101
The Syk protein tyrosine kinase is essential for Fcgamma receptor signaling in macrophages and neutrophils.
###end article-title 101
###begin article-title 102
Pre-existing glomerular immune complexes induce polymorphonuclear cell recruitment through an Fc receptor-dependent respiratory burst: Potential role in the perpetuation of immune nephritis.
###end article-title 102
###begin article-title 103
###xml 39 42 39 42 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">hck</sup>
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>hck</sup></italic>
###xml 50 55 50 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">c-fgr</sup>
###xml 50 55 50 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML"><sup>c-fgr</sup></italic>
Deficiency of Src family kinases p59/61hck and p58c-fgr results in defective adhesion-dependent neutrophil functions.
###end article-title 103
###begin article-title 104
Adhesion-dependent degranulation of neutrophils requires the Src family kinases Fgr and Hck.
###end article-title 104
###begin article-title 105
Integrin signaling in neutrophils and macrophages uses adaptors containing immunoreceptor tyrosine-based activation motifs.
###end article-title 105
###begin article-title 106
Syk is required for integrin signaling in neutrophils.
###end article-title 106
###begin article-title 107
Evidence for the requirement of ITAM domains but not SLP-76/Gads interaction for integrin signaling in hematopoietic cells.
###end article-title 107
###begin article-title 108
###xml 21 22 17 18 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">V</sub>
Syk, c-Src, the alphaVbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption.
###end article-title 108
###begin article-title 109
An ITAM-signaling pathway controls cross-presentation of particulate but not soluble antigens in dendritic cells.
###end article-title 109
###begin article-title 110
Developmental neuronal death in hippocampus requires the microglial CD11b integrin and DAP12 immunoreceptor.
###end article-title 110
###begin article-title 111
###xml 37 38 34 35 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 47 48 41 42 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
Immunoreceptor-like signaling by beta2 and beta3 integrins.
###end article-title 111
###begin article-title 112
Essential role of the tyrosine kinase substrate phospholipase C-gamma1 in mammalian growth and development.
###end article-title 112
###begin article-title 113
###xml 64 68 <span type="species:ncbi:10090">mice</span>
Absence of erythrogenesis and vasculogenesis in Plcg1-deficient mice.
###end article-title 113
###begin article-title 114
Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors.
###end article-title 114
###begin article-title 115
Phospholipase Cgamma2 is essential for specific functions of FcϵR and FcgammaR.
###end article-title 115
###begin article-title 116
###xml 14 15 10 11 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 19 20 12 13 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
Integrin alpha2beta1 mediates outside-in regulation of platelet spreading on collagen through activation of Src kinases and PLCgamma2.
###end article-title 116
###begin article-title 117
###xml 50 53 42 45 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IIb</sub>
###xml 57 58 46 47 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">3</sub>
A critical role for phospholipase Cgamma2 in alphaIIbbeta3-mediated platelet spreading.
###end article-title 117
###begin article-title 118
###xml 105 109 <span type="species:ncbi:10090">mice</span>
Neutrophil-mediated oxidative burst and host defense are controlled by a Vav-PLCgamma2 signaling axis in mice.
###end article-title 118
###begin article-title 119
Evolving concepts of rheumatoid arthritis.
###end article-title 119
###begin article-title 120
Organ-specific disease provoked by systemic autoimmunity.
###end article-title 120
###begin article-title 121
From systemic T cell self-reactivity to organ-specific autoimmune disease via immunoglobulins.
###end article-title 121
###begin article-title 122
###xml 69 75 <span type="species:ncbi:10090">murine</span>
Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis.
###end article-title 122
###begin article-title 123
###xml 67 71 <span type="species:ncbi:10090">mice</span>
Collagen type II-specific monoclonal antibody-induced arthritis in mice: Description of the disease and the influence of age, sex, and genes.
###end article-title 123
###begin article-title 124
Essential role of neutrophils in anti-type II collagen antibody and lipopolysaccharide-induced arthritis.
###end article-title 124
###begin article-title 125
Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis.
###end article-title 125
###begin article-title 126
Critical role for granulocyte colony-stimulating factor in inflammatory arthritis.
###end article-title 126
###begin article-title 127
###xml 32 33 32 33 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
Neutrophil-derived leukotriene B4 is required for inflammatory arthritis.
###end article-title 127
###begin article-title 128
###xml 42 43 42 43 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">4</sub>
A unique requirement for the leukotriene B4 receptor BLT1 for neutrophil recruitment in inflammatory arthritis.
###end article-title 128
###begin article-title 129
###xml 122 126 <span type="species:ncbi:10090">mice</span>
Deregulation of peripheral B-cell development in enhanced severity of collagen-induced arthritis in FcgammaRIIB-deficient mice.
###end article-title 129
###begin article-title 130
Induction and suppression of collagen-induced arthritis is dependent on distinct Fcgamma receptors.
###end article-title 130
###begin article-title 131
Arthritis critically dependent on innate immune system players.
###end article-title 131
###begin article-title 132
Essential role of Fcgamma receptors in anti-type II collagen antibody-induced arthritis.
###end article-title 132
###begin article-title 133
Development of proteoglycan-induced arthritis is critically dependent on Fcgamma receptor type III expression.
###end article-title 133
###begin article-title 134
Expression of FcgammaRIII is required for development of collagen-induced arthritis.
###end article-title 134
###begin article-title 135
Coordinate expression of activating Fcgamma receptors I and III and inhibiting Fcgamma receptor type II in the determination of joint inflammation and cartilage destruction during immune complex-mediated arthritis.
###end article-title 135
###begin article-title 136
FcgammaRI (CD64) contributes substantially to severity of arthritis, hypersensitivity responses, and protection from bacterial infection.
###end article-title 136
###begin article-title 137
Destructive arthritis in the absence of both FcgammaRI and FcgammaRIII.
###end article-title 137
###begin article-title 138
The complex role of Fcgamma receptors in the pathology of arthritis.
###end article-title 138
###begin article-title 139
Manifestations of inflammatory arthritis are critically dependent on LFA-1.
###end article-title 139
###begin article-title 140
###xml 100 101 96 97 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">M</sub>
###xml 105 106 98 99 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Fibrin(ogen) exacerbates inflammatory joint disease through a mechanism linked to the integrin alphaMbeta2 binding motif.
###end article-title 140
###begin article-title 141
###xml 77 83 <span type="species:ncbi:10090">murine</span>
Critical but overlapping role of FcgammaRIII and FcgammaRIV in activation of murine neutrophils by immobilized immune complexes.
###end article-title 141
###begin article-title 142
###xml 88 92 <span type="species:ncbi:10090">mice</span>
Phospholipase Cgamma2 is necessary for separation of blood and lymphatic vasculature in mice.
###end article-title 142
###begin article-title 143
Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk.
###end article-title 143
###begin article-title 144
Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.
###end article-title 144
###begin article-title 145
###xml 38 43 <span type="species:ncbi:9606">human</span>
Cytokine-induced respiratory burst of human neutrophils: dependence on extracellular matrix proteins and CD11/CD18 integrins.
###end article-title 145
###begin article-title 146
Responses of neutrophils to anti-integrin antibodies depends on costimulation through low affinity FcgammaRs: full activation requires both integrin and nonintegrin signals.
###end article-title 146
###begin article-title 147
Treatment of intractable rheumatoid arthritis with total lymphoid irradiation.
###end article-title 147
###begin article-title 148
A crucial role for macrophages in the pathology of K/BxN serum-induced arthritis.
###end article-title 148
###begin article-title 149
Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease.
###end article-title 149
###begin article-title 150
Mast cells: A cellular link between autoantibodies and inflammatory arthritis.
###end article-title 150
###begin article-title 151
###xml 27 31 27 31 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">W-sh</sup>
###xml 24 31 24 31 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Kit<sup>W-sh</sup></italic>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Mast cell deficiency in KitW-sh mice does not impair antibody-mediated arthritis.
###end article-title 151
###begin article-title 152
Mast cell growth, differentiation, and death.
###end article-title 152
###begin article-title 153
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Development of mast cells from grafted bone marrow cells in irradiated mice.
###end article-title 153
###begin article-title 154
SLP-76 regulates Fcgamma receptor and integrin signaling in neutrophils.
###end article-title 154
###begin article-title 155
###xml 30 31 27 28 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
Vav GEFs are required for beta2 integrin-dependent functions of neutrophils.
###end article-title 155
###begin article-title 156
###xml 157 161 153 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">phox</sup>
Vav proteins in neutrophils are required for FcgammaR-mediated signaling to Rac GTPases and nicotinamide adenine dinucleotide phosphate oxidase component p40phox.
###end article-title 156
###begin article-title 157
###xml 92 93 89 90 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
The Vav binding site of the non-receptor tyrosine kinase Syk at Tyr 348 is critical for beta2 integrin (CD11/CD18)-mediated neutrophil migration.
###end article-title 157
###begin article-title 158
Spleen tyrosine kinase Syk is critical for sustained leukocyte adhesion during inflammation in vivo.
###end article-title 158
###begin article-title 159
An important role of phospholipase Cgamma1 in pre-B-cell development and allelic exclusion.
###end article-title 159
###begin article-title 160
Phospholipase Cgamma2 mediates RANKL-stimulated lymph node organogenesis and osteoclastogenesis.
###end article-title 160
###begin article-title 161
###xml 0 15 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 27 32 <span type="species:ncbi:9606">human</span>
Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis.
###end article-title 161
###begin article-title 162
###xml 100 104 <span type="species:ncbi:10090">mice</span>
Altered thymic T-cell selection due to a mutation of the ZAP-70 gene causes autoimmune arthritis in mice.
###end article-title 162
###begin article-title 163
###xml 83 84 83 84 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis.
###end article-title 163
###begin article-title 164
###xml 6 7 3 4 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sub>
A beta1 integrin signaling pathway involving Src-family kinases, Cbl and PI-3 kinase is required for macrophage spreading and migration.
###end article-title 164
###begin article-title 165
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Perinatal lethality and blocked B-cell development in mice lacking the tyrosine kinase Syk.
###end article-title 165
###begin article-title 166
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Spontaneous skin ulceration and defective T cell function in CD18 null mice.
###end article-title 166
###begin article-title 167
FcR gamma-chain deletion results in pleiotrophic effector cell defects.
###end article-title 167
###begin article-title 168
G-protein-coupled receptor signaling in Syk-deficient neutrophils and mast cells.
###end article-title 168
###begin article-title 169
FcgammaRIV: A novel FcR with distinct IgG subclass specificity.
###end article-title 169
###begin article-title 170
Kinase pathways in chemoattractant-induced degranulation of neutrophils: The role of p38 mitogen-activated protein kinase activated by Src family kinases.
###end article-title 170
###begin article-title 171
Rac regulates its effector phospholipase Cgamma2 through interaction with a split pleckstrin homology domain.
###end article-title 171
###begin article-title 172
A versatile video image analysis system for microcirculatory research.
###end article-title 172
###begin article-title 173
Analysis of leukocyte rolling in vivo and in vitro.
###end article-title 173
###begin article-title 174
Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation.
###end article-title 174
###begin p 175
Abbreviations used: ERK, extracellular signal-regulated kinase; ITAM, immunoreceptor tyrosine-based activation motif; PLC, phospholipase C.
###end p 175

